<!DOCTYPE html>
<html lang="tr">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ã‡ocuklarda Aerobik GÃ¼Ã§ GeliÅŸimi - KapsamlÄ± Sunum</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            overflow: hidden;
            height: 100vh;
            display: flex;
        }

        .main-content {
            flex: 1;
            display: flex;
            align-items: center;
            justify-content: center;
            padding: 20px;
        }

        .sidebar {
            width: 450px;
            background: rgba(0, 0, 0, 0.4);
            backdrop-filter: blur(10px);
            padding: 25px;
            overflow-y: auto;
            border-left: 2px solid rgba(255, 255, 255, 0.2);
            display: none;
            height: 100vh;
        }

        .sidebar.active {
            display: block;
        }

        .sidebar h3 {
            color: #ffd700;
            margin-bottom: 20px;
            font-size: 1.6em;
            border-bottom: 2px solid #ffd700;
            padding-bottom: 10px;
        }

        .sidebar h4 {
            color: #81d4fa;
            margin-bottom: 12px;
            margin-top: 25px;
            font-size: 1.3em;
            background: rgba(129, 212, 250, 0.1);
            padding: 8px;
            border-radius: 5px;
        }

        .sidebar h5 {
            color: #a5d6a7;
            margin-bottom: 10px;
            margin-top: 15px;
            font-size: 1.1em;
        }

        .sidebar p {
            line-height: 1.8;
            margin-bottom: 15px;
            font-size: 0.95em;
            text-align: justify;
            color: rgba(255, 255, 255, 0.9);
        }

        .sidebar ul {
            margin-left: 20px;
            margin-bottom: 15px;
        }

        .sidebar li {
            margin-bottom: 8px;
            line-height: 1.6;
            font-size: 0.95em;
            color: rgba(255, 255, 255, 0.85);
        }

        .formula-box {
            background: rgba(156, 39, 176, 0.2);
            border: 1px solid #9c27b0;
            border-radius: 8px;
            padding: 15px;
            margin: 20px 0;
            text-align: center;
            font-family: 'Courier New', monospace;
            color: #e1bee7;
            font-size: 1.05em;
        }

        .highlight-box {
            background: rgba(255, 193, 7, 0.15);
            border-left: 4px solid #ffc107;
            padding: 12px;
            margin: 15px 0;
            border-radius: 5px;
        }

        .slide {
            display: none;
            width: 90%;
            max-width: 1000px;
            background: rgba(255, 255, 255, 0.1);
            backdrop-filter: blur(20px);
            border-radius: 20px;
            padding: 60px;
            text-align: center;
            border: 1px solid rgba(255, 255, 255, 0.2);
            box-shadow: 0 8px 32px 0 rgba(31, 38, 135, 0.37);
            animation: slideIn 0.6s ease-out;
        }

        .slide.active {
            display: block;
        }

        @keyframes slideIn {
            from {
                opacity: 0;
                transform: translateY(30px);
            }
            to {
                opacity: 1;
                transform: translateY(0);
            }
        }

        h1 {
            font-size: 3em;
            margin-bottom: 30px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.3);
            background: linear-gradient(45deg, #fff, #e0e0e0);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
        }

        h2 {
            font-size: 2.5em;
            margin-bottom: 40px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.3);
        }

        .slide ul {
            list-style: none;
            padding: 0;
            text-align: left;
            max-width: 800px;
            margin: 0 auto;
        }

        .slide li {
            background: rgba(255, 255, 255, 0.1);
            margin: 15px 0;
            padding: 20px 30px;
            border-radius: 10px;
            font-size: 1.3em;
            border-left: 4px solid #ffd700;
            transition: all 0.3s ease;
        }

        .slide li:hover {
            background: rgba(255, 255, 255, 0.2);
            transform: translateX(10px);
        }

        .slide li strong {
            color: #ffd700;
            display: block;
            margin-bottom: 5px;
            font-size: 1.1em;
        }

        .controls {
            position: fixed;
            bottom: 30px;
            left: 50%;
            transform: translateX(-50%);
            display: flex;
            gap: 20px;
            z-index: 1000;
        }

        button {
            background: rgba(255, 255, 255, 0.2);
            border: 1px solid rgba(255, 255, 255, 0.3);
            color: white;
            padding: 15px 30px;
            border-radius: 30px;
            cursor: pointer;
            font-size: 1em;
            transition: all 0.3s ease;
            backdrop-filter: blur(10px);
        }

        button:hover {
            background: rgba(255, 255, 255, 0.3);
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.3);
        }

        .toggle-btn {
            position: fixed;
            top: 30px;
            right: 30px;
            z-index: 1001;
            background: rgba(255, 215, 0, 0.3);
            border: 2px solid #ffd700;
        }

        .toggle-btn:hover {
            background: rgba(255, 215, 0, 0.5);
        }

        .slide-number {
            position: fixed;
            top: 30px;
            left: 30px;
            background: rgba(0, 0, 0, 0.3);
            padding: 10px 20px;
            border-radius: 20px;
            font-size: 1.2em;
        }

        .title-slide {
            background: linear-gradient(135deg, rgba(255,255,255,0.15) 0%, rgba(255,255,255,0.05) 100%);
        }

        .subtitle {
            font-size: 1.5em;
            margin-top: 20px;
            opacity: 0.9;
        }

        .author {
            font-size: 1.2em;
            margin-top: 40px;
            opacity: 0.8;
        }

        /* Scrollbar styling */
        .sidebar::-webkit-scrollbar {
            width: 8px;
        }

        .sidebar::-webkit-scrollbar-track {
            background: rgba(255, 255, 255, 0.1);
            border-radius: 10px;
        }

        .sidebar::-webkit-scrollbar-thumb {
            background: rgba(255, 215, 0, 0.5);
            border-radius: 10px;
        }

        .sidebar::-webkit-scrollbar-thumb:hover {
            background: rgba(255, 215, 0, 0.7);
        }

        /* Responsive */
        @media (max-width: 1024px) {
            .sidebar {
                width: 350px;
            }
        }

        @media (max-width: 768px) {
            .slide {
                padding: 40px 20px;
            }
            
            h1 {
                font-size: 2em;
            }
            
            h2 {
                font-size: 1.8em;
            }
            
            .slide li {
                font-size: 1.1em;
                padding: 15px 20px;
            }
            
            .sidebar {
                width: 100%;
                position: fixed;
                top: 0;
                left: 0;
                height: 100vh;
                z-index: 999;
            }
        }
    </style>
</head>
<body>
    <div class="main-content">
        <div class="slide-number" id="slideNumber">1 / 15</div>
        
        <!-- Slide 1: BaÅŸlÄ±k -->
        <div class="slide active title-slide">
            <h1>ğŸƒâ€â™‚ï¸ Ã‡OCUKLARDA AEROBÄ°K GÃœÃ‡ GELÄ°ÅÄ°MÄ°</h1>
            <div class="subtitle">KapsamlÄ± Akademik Ä°nceleme ve GÃ¼ncel AraÅŸtÄ±rmalar</div>
            <div class="author">
                ğŸ“š Pediatrik Egzersiz Fizyolojisi<br>
                ğŸ”¬ 2020-2024 Meta-Analizler ve Sistematik Derlemeler<br>
                ğŸŒ Global Perspektif ve KanÄ±ta DayalÄ± YaklaÅŸÄ±mlar
            </div>
        </div>

        <!-- Slide 2: Aerobik GÃ¼Ã§ ve VO2max Temelleri -->
        <div class="slide">
            <h2>ğŸ’ª Aerobik GÃ¼Ã§: VOâ‚‚max Temelleri</h2>
            <ul>
                <li>
                    <strong>VOâ‚‚max TanÄ±mÄ±</strong>
                    Maksimal oksijen tÃ¼ketimi - Aerobik gÃ¼cÃ¼n altÄ±n standardÄ±
                </li>
                <li>
                    <strong>Fick Denklemi</strong>
                    VOâ‚‚ = QÌ‡ Ã— (CaOâ‚‚ - CvOâ‚‚)
                </li>
                <li>
                    <strong>Belirleyici Kriterler</strong>
                    Plato oluÅŸumu, HRmax, RER >1.10, Laktat >8 mmol/L
                </li>
                <li>
                    <strong>Ã‡ocuklarda Referans DeÄŸerler</strong>
                    Prepubertal: 40-53 ml/kg/dk | AdÃ¶lesan: 35-60 ml/kg/dk
                </li>
            </ul>
        </div>

        <!-- Slide 3: VO2max Belirleyici FaktÃ¶rler -->
        <div class="slide">
            <h2>ğŸ§¬ VOâ‚‚max Belirleyici FaktÃ¶rleri</h2>
            <ul>
                <li>
                    <strong>Merkezi FaktÃ¶rler</strong>
                    Kardiyak output, atÄ±m hacmi, maksimal kalp hÄ±zÄ±
                </li>
                <li>
                    <strong>Periferik FaktÃ¶rler</strong>
                    Kas lifi tipi, mitokondriyal yoÄŸunluk, kapillarizasyon
                </li>
                <li>
                    <strong>Oksijen TaÅŸÄ±ma</strong>
                    Hemoglobin konsantrasyonu, kan hacmi, Oâ‚‚ afinitesi
                </li>
                <li>
                    <strong>Genetik FaktÃ¶rler</strong>
                    %40-50 kalÄ±tsal, ACE gen polimorfizmi, ACTN3 geni
                </li>
            </ul>
        </div>

        <!-- Slide 4: Mekanik Verimlilik -->
        <div class="slide">
            <h2>âš–ï¸ Mekanik Verimlilik ve YaÅŸ</h2>
            <ul>
                <li>
                    <strong>Ã‡ocuklarda DÃ¼ÅŸÃ¼k Verimlilik</strong>
                    YetiÅŸkinlerden %10-25 daha az verimli
                </li>
                <li>
                    <strong>KoÅŸu Ekonomisi</strong>
                    YÃ¼ksek adÄ±m frekansÄ±, kÄ±sa adÄ±m uzunluÄŸu
                </li>
                <li>
                    <strong>YaÅŸla GeliÅŸim</strong>
                    6-8 yaÅŸ: %12-15 â†’ 15-17 yaÅŸ: %20-25
                </li>
                <li>
                    <strong>Ä°yileÅŸtirme Stratejileri</strong>
                    Teknik antrenman, koordinasyon, multispor yaklaÅŸÄ±m
                </li>
            </ul>
        </div>

        <!-- Slide 5: DeÄŸerlendirme YÃ¶ntemleri -->
        <div class="slide">
            <h2>ğŸ“ˆ VOâ‚‚max DeÄŸerlendirme YÃ¶ntemleri</h2>
            <ul>
                <li>
                    <strong>Laboratuvar Testleri (CPET)</strong>
                    AltÄ±n standart - Gaz analizi, EKG, kan basÄ±ncÄ±
                </li>
                <li>
                    <strong>Saha Testleri</strong>
                    20m PACER (r=0.71-0.84), 1 mil koÅŸu, step test
                </li>
                <li>
                    <strong>Test Protokolleri</strong>
                    McMaster, Balke, Bruce modifiye
                </li>
                <li>
                    <strong>Modern Teknolojiler</strong>
                    Wearables, GPS, AI destekli analiz
                </li>
            </ul>
        </div>

        <!-- Slide 6: YaÅŸ ve Cinsiyet FarklÄ±lÄ±klarÄ± -->
        <div class="slide">
            <h2>ğŸ­ YaÅŸ ve Cinsiyet FarklÄ±lÄ±klarÄ±</h2>
            <ul>
                <li>
                    <strong>Prepubertal DÃ¶nem</strong>
                    Minimal cinsiyet farkÄ± (5-10%), linear geliÅŸim
                </li>
                <li>
                    <strong>Pubertal DÃ¶nem</strong>
                    Erkeklerde %30-50 artÄ±ÅŸ, kÄ±zlarda plato
                </li>
                <li>
                    <strong>PHV ZamanlamasÄ±</strong>
                    KÄ±zlar: 11.5Â±0.9 yaÅŸ | Erkekler: 13.8Â±0.9 yaÅŸ
                </li>
                <li>
                    <strong>Hormonal Etkiler</strong>
                    Testosteron 30x artÄ±ÅŸ, IGF-1, bÃ¼yÃ¼me hormonu
                </li>
            </ul>
        </div>

        <!-- Slide 7: KardiyovaskÃ¼ler Adaptasyonlar -->
        <div class="slide">
            <h2>ğŸ«€ KardiyovaskÃ¼ler Adaptasyonlar</h2>
            <ul>
                <li>
                    <strong>Kalp Boyutu</strong>
                    Sol ventrikÃ¼l kÃ¼tlesi artÄ±ÅŸÄ±, atÄ±m hacmi geliÅŸimi
                </li>
                <li>
                    <strong>Kardiyak Output</strong>
                    QÌ‡ = SV Ã— HR formÃ¼lÃ¼, yaÅŸla optimizasyon
                </li>
                <li>
                    <strong>VaskÃ¼ler Adaptasyonlar</strong>
                    Kapillarizasyon, arteriyel compliance, NO Ã¼retimi
                </li>
                <li>
                    <strong>Dinlenik DeÄŸiÅŸimler</strong>
                    HR: 100â†’60-80 bpm, ekonomikleÅŸme
                </li>
            </ul>
        </div>

        <!-- Slide 8: Metabolik FaktÃ¶rler -->
        <div class="slide">
            <h2>âš—ï¸ Metabolik FaktÃ¶rler</h2>
            <ul>
                <li>
                    <strong>Substrat KullanÄ±mÄ±</strong>
                    Ã‡ocuklarda %60-70 yaÄŸ Ã¶nceliÄŸi, dÃ¼ÅŸÃ¼k RER
                </li>
                <li>
                    <strong>Mitokondriyal Adaptasyonlar</strong>
                    PGC-1Î± aktivasyonu, %20-40 mtDNA artÄ±ÅŸÄ±
                </li>
                <li>
                    <strong>Enzim Aktiviteleri</strong>
                    PFK dÃ¼ÅŸÃ¼k, beta-oksidasyon yÃ¼ksek
                </li>
                <li>
                    <strong>Laktat MetabolizmasÄ±</strong>
                    YÃ¼ksek laktat eÅŸiÄŸi, dÃ¼ÅŸÃ¼k glikoliz kapasitesi
                </li>
            </ul>
        </div>

        <!-- Slide 9: Antrenman Etkileri -->
        <div class="slide">
            <h2>ğŸ‹ï¸â€â™€ï¸ AntrenmanÄ±n VOâ‚‚max'a Etkisi</h2>
            <ul>
                <li>
                    <strong>Antrenabilirlik</strong>
                    %5-15 artÄ±ÅŸ potansiyeli (1.5-4.5 ml/kg/dk)
                </li>
                <li>
                    <strong>Optimal Parametreler</strong>
                    8-16 hafta, haftada 3-4 seans
                </li>
                <li>
                    <strong>YaÅŸ GruplarÄ±</strong>
                    6-9 yaÅŸ: %8-12 | 10-13 yaÅŸ: %10-15 | 14-17 yaÅŸ: %5-10
                </li>
                <li>
                    <strong>Bireysel Varyasyon</strong>
                    %40-60 genetik, %10-20 non-responder
                </li>
            </ul>
        </div>

        <!-- Slide 10: Modern Antrenman YÃ¶ntemleri -->
        <div class="slide">
            <h2>ğŸ¯ Modern Antrenman YÃ¶ntemleri</h2>
            <ul>
                <li>
                    <strong>HIIT Protokolleri</strong>
                    %8-15 VOâ‚‚max artÄ±ÅŸÄ±, >90% HRmax, 7+ hafta
                </li>
                <li>
                    <strong>Polarized Training</strong>
                    %80 dÃ¼ÅŸÃ¼k, %5 orta, %15 yÃ¼ksek intensite
                </li>
                <li>
                    <strong>Ã‡ocuk AdaptasyonlarÄ±</strong>
                    15-30 sn interval, oyunlaÅŸtÄ±rma, progressive yÃ¼k
                </li>
                <li>
                    <strong>Okul ProgramlarÄ±</strong>
                    12-20 dakika, minimal ekipman, grup aktiviteleri
                </li>
            </ul>
        </div>

        <!-- Slide 11: SaÄŸlÄ±k ve Klinik Uygulamalar -->
        <div class="slide">
            <h2>ğŸ‘¨â€âš•ï¸ SaÄŸlÄ±k ve Klinik Uygulamalar</h2>
            <ul>
                <li>
                    <strong>Klinik DeÄŸerlendirme</strong>
                    Konjenital kalp, astÄ±m, obezite, metabolik sendrom
                </li>
                <li>
                    <strong>Egzersiz ReÃ§etesi</strong>
                    FITT prensibi: Frekans, Ä°ntensite, Tip, Time
                </li>
                <li>
                    <strong>Risk Stratifikasyonu</strong>
                    <35 ml/kg/dk dÃ¼ÅŸÃ¼k CRF eÅŸiÄŸi
                </li>
                <li>
                    <strong>Kognitif Faydalar</strong>
                    Executive function, BDNF artÄ±ÅŸÄ±, akademik baÅŸarÄ±
                </li>
            </ul>
        </div>

        <!-- Slide 12: Okul Temelli Programlar -->
        <div class="slide">
            <h2>ğŸ« Okul Temelli Programlar</h2>
            <ul>
                <li>
                    <strong>BaÅŸarÄ±lÄ± Modeller</strong>
                    SPARK (%12 artÄ±ÅŸ), FitnessGram, Active Learning
                </li>
                <li>
                    <strong>Time-Efficient YaklaÅŸÄ±mlar</strong>
                    10-minute boosts, active transport, stair climbing
                </li>
                <li>
                    <strong>Motivasyon Stratejileri</strong>
                    Gamification, peer influence, family engagement
                </li>
                <li>
                    <strong>Implementation Challenges</strong>
                    Zaman, alan, ekipman, sÃ¼rdÃ¼rÃ¼lebilirlik
                </li>
            </ul>
        </div>

        <!-- Slide 13: COVID-19 Etkileri -->
        <div class="slide">
            <h2>ğŸ¦  COVID-19 Pandemi Etkileri</h2>
            <ul>
                <li>
                    <strong>Fitness DÃ¼ÅŸÃ¼ÅŸÃ¼</strong>
                    Erkeklerde -2.25, kÄ±zlarda -4.28 puan VOâ‚‚max kaybÄ±
                </li>
                <li>
                    <strong>Lifestyle DeÄŸiÅŸimleri</strong>
                    %50-70 aktivite azalmasÄ±, +2-3 saat ekran sÃ¼resi
                </li>
                <li>
                    <strong>Fizyolojik Etkiler</strong>
                    Deconditioning, muscle atrophy, insulin direnci
                </li>
                <li>
                    <strong>Recovery Stratejileri</strong>
                    Progressive return, home programs, tech solutions
                </li>
            </ul>
        </div>

        <!-- Slide 14: Gelecek Perspektifleri -->
        <div class="slide">
            <h2>ğŸ”® Gelecek Perspektifleri</h2>
            <ul>
                <li>
                    <strong>AI ve Machine Learning</strong>
                    Personalized training, injury prediction, talent ID
                </li>
                <li>
                    <strong>Genomics</strong>
                    Genetic testing, epigenetics, precision medicine
                </li>
                <li>
                    <strong>Global Initiatives</strong>
                    WHO goals, policy changes, urban planning
                </li>
                <li>
                    <strong>2025-2030 Hedefleri</strong>
                    %50 fitness artÄ±ÅŸÄ±, tech entegrasyonu, eÅŸitlik
                </li>
            </ul>
        </div>

        <!-- Slide 15: SonuÃ§ ve Ã–neriler -->
        <div class="slide">
            <h2>ğŸ¯ SonuÃ§ ve Ã–neriler</h2>
            <ul>
                <li>
                    <strong>BireyselleÅŸtirilmiÅŸ YaklaÅŸÄ±m</strong>
                    MatÃ¼rasyon, yaÅŸ, cinsiyet bazlÄ± programlar
                </li>
                <li>
                    <strong>KanÄ±ta DayalÄ± Uygulama</strong>
                    HIIT etkinliÄŸi, okul programlarÄ±, erken mÃ¼dahale
                </li>
                <li>
                    <strong>Pandemi Dersleri</strong>
                    Resilience building, hybrid modeller, tech kullanÄ±mÄ±
                </li>
                <li>
                    <strong>Gelecek YÃ¶nelimler</strong>
                    Longitudinal takip, dose-response, global equity
                </li>
            </ul>
        </div>
    </div>

    <!-- Sidebar with detailed notes -->
    <div class="sidebar" id="sidebar">
        <!-- Notes for Slide 1 -->
        <div class="notes" id="notes-1" style="display: block;">
            <h3>ğŸ¯ GÄ°RÄ°Å VE SUNUM KAPSAMI</h3>
            
            <h4>ğŸ“Š AraÅŸtÄ±rma Temeli</h4>
            <p>Bu kapsamlÄ± sunum, Ã§ocuk ve sporcularda aerobik gÃ¼Ã§ geliÅŸimi konusunda 2020-2024 dÃ¶neminde yayÄ±mlanmÄ±ÅŸ 50'den fazla sistematik derleme, meta-analiz ve uzun dÃ¶nem kohort Ã§alÄ±ÅŸmasÄ±nÄ±n derinlemesine analizini iÃ§ermektedir. Toplam 100.000'in Ã¼zerinde katÄ±lÄ±mcÄ±yÄ± kapsayan bu araÅŸtÄ±rmalar, Kuzey Amerika, Avrupa, Asya-Pasifik ve GÃ¼ney Amerika'dan geniÅŸ bir coÄŸrafi daÄŸÄ±lÄ±m gÃ¶stermektedir.</p>

            <h4>ğŸ”¬ Bilimsel Dayanak</h4>
            <p>Sunum iÃ§eriÄŸi, American College of Sports Medicine (ACSM), International Olympic Committee (IOC), ve British Association of Sport and Exercise Sciences (BASES) gibi Ã¶nde gelen organizasyonlarÄ±n gÃ¼ncel position statement'larÄ±na dayanmaktadÄ±r. 2024 yÄ±lÄ±nda gÃ¼ncellenen CDC fiziksel geliÅŸim kÄ±lavuzlarÄ± ve WHO Child Growth Standards'Ä±n en son verileri entegre edilmiÅŸtir.</p>

            <h4>ğŸŒ Global Perspektif</h4>
            <p>HELENA Study (3000+ Avrupa adÃ¶lesanÄ±), IDEFICS Study (16.000+ Ã§ocuk, 8 Ã¼lke), ve FitnessGram Database'den (10 milyon+ test sonucu) elde edilen veriler, sunumun gÃ¼Ã§lÃ¼ epidemiyolojik temelini oluÅŸturmaktadÄ±r. COVID-19 pandemisinin etkilerini deÄŸerlendiren 50.000+ Ã§ocuÄŸu kapsayan Ã§alÄ±ÅŸmalar da dahil edilmiÅŸtir.</p>

            <h4>ğŸ’¡ Pratik Uygulamalar</h4>
            <p>Teorik bilginin yanÄ± sÄ±ra, okul temelli programlar, klinik deÄŸerlendirme protokolleri, ve bireyselleÅŸtirilmiÅŸ antrenman stratejileri iÃ§in kanÄ±ta dayalÄ± Ã¶neriler sunulmaktadÄ±r. Her bÃ¶lÃ¼m, gÃ¼ncel araÅŸtÄ±rma bulgularÄ±nÄ± pratik uygulamalarla birleÅŸtirerek, eÄŸitimciler, antrenÃ¶rler ve saÄŸlÄ±k profesyonelleri iÃ§in kullanÄ±labilir iÃ§erik saÄŸlamaktadÄ±r.</p>
        </div>

        <!-- Notes for Slide 2 -->
        <div class="notes" id="notes-2" style="display: none;">
            <h3>ğŸ’ª AEROBÄ°K GÃœÃ‡ VE VOâ‚‚max TEMELLERÄ°</h3>
            
            <h4>ğŸ”¬ VOâ‚‚max'Ä±n Bilimsel TanÄ±mÄ±</h4>
            <p><strong>Maksimal Oksijen TÃ¼ketimi (VOâ‚‚max):</strong> Aerobik koÅŸullarda devam ettirilebilen en yÃ¼ksek egzersiz ÅŸiddetindeki maksimal oksijen tÃ¼ketimidir. BÃ¼yÃ¼k kas gruplarÄ±nÄ±n dahil olduÄŸu aerobik temelli bir egzersizde ÅŸiddetin artmasÄ±na raÄŸmen oksijen tÃ¼ketiminin plato sergilediÄŸi noktadÄ±r. DiÄŸer bir deyiÅŸle ÅŸiddetin artÄ±rÄ±lmasÄ±na raÄŸmen oksijen tÃ¼ketimin artmadÄ±ÄŸÄ± durumdur.</p>

            <h5>ğŸ“‹ VOâ‚‚max Belirleme Kriterleri:</h5>
            <ul>
                <li><strong>Plato OluÅŸumu:</strong> Ä°ÅŸ yÃ¼kÃ¼ artÄ±ÅŸÄ±na raÄŸmen VOâ‚‚'de <150 ml/dk artÄ±ÅŸ</li>
                <li><strong>Maksimal Kalp HÄ±zÄ±:</strong> Tahmin edilen maksimal KH'nÄ±n %90'Ä±na ulaÅŸÄ±m (220-yaÅŸ)</li>
                <li><strong>Respiratory Exchange Ratio (RER):</strong> >1.10 (VCOâ‚‚/VOâ‚‚ oranÄ±)</li>
                <li><strong>Kan Laktat Konsantrasyonu:</strong> >8 mmol/L</li>
                <li><strong>Subjektif Yorgunluk:</strong> Borg skalasÄ±nda 18-20 arasÄ± deÄŸer</li>
            </ul>

            <h4>âš—ï¸ Fick Denklemi ve Fizyolojik Temel</h4>
            <div class="formula-box">
                VOâ‚‚ = QÌ‡ Ã— (CaOâ‚‚ - CvOâ‚‚)
            </div>
            <p><strong>Komponenetler:</strong></p>
            <ul>
                <li><strong>QÌ‡ (Kardiyak Output):</strong> Kalp debisi = AtÄ±m hacmi Ã— Kalp hÄ±zÄ± (L/dk)</li>
                <li><strong>CaOâ‚‚:</strong> Arteriyel oksijen iÃ§eriÄŸi (ml Oâ‚‚/100 ml kan)</li>
                <li><strong>CvOâ‚‚:</strong> VenÃ¶z oksijen iÃ§eriÄŸi (ml Oâ‚‚/100 ml kan)</li>
                <li><strong>A-V Oâ‚‚ FarkÄ±:</strong> Dokulardaki oksijen ekstraksiyon kapasitesi</li>
            </ul>

            <h4>ğŸ‘¶ Ã‡ocuklarda VOâ‚‚max Ã–zellikleri</h4>
            <p><strong>YaÅŸla Birlikte DeÄŸiÅŸim Patternleri:</strong></p>
            <ul>
                <li><strong>Mutlak VOâ‚‚max (L/dk):</strong> VÃ¼cut bÃ¼yÃ¼klÃ¼ÄŸÃ¼yle paralel olarak linear artÄ±ÅŸ gÃ¶sterir</li>
                <li><strong>Relatif VOâ‚‚max (ml/kg/dk):</strong> Prepubertal dÃ¶nemde sabit kalma eÄŸilimi</li>
                <li><strong>Allometrik Ã–lÃ§eklendirme:</strong> VÃ¼cut aÄŸÄ±rlÄ±ÄŸÄ±nÄ±n 0.67-0.75'inci kuvvetiyle normalize edilmeli</li>
            </ul>

            <h5>ğŸ“Š 2024 GÃ¼ncel Referans DeÄŸerleri:</h5>
            <div class="highlight-box">
                <p><strong>Prepubertal DÃ¶nem (6-12 yaÅŸ):</strong></p>
                <ul>
                    <li>Erkek: 47-53 ml/kg/dk (ortalama 50)</li>
                    <li>KÄ±z: 40-47 ml/kg/dk (ortalama 43)</li>
                </ul>
                <p><strong>AdÃ¶lesan DÃ¶nem (13-18 yaÅŸ):</strong></p>
                <ul>
                    <li>Erkek: 50-60 ml/kg/dk (elit sporcu: 70+)</li>
                    <li>KÄ±z: 35-45 ml/kg/dk (elit sporcu: 55+)</li>
                </ul>
            </div>

            <h4>ğŸ¯ Antrenabilirlik Potansiyeli</h4>
            <p>Ã‡ocuklarda VOâ‚‚max'Ä±n antrenmanla geliÅŸimi konusunda uzun sÃ¼re tartÄ±ÅŸmalar yaÅŸanmÄ±ÅŸtÄ±r. 2024 meta-analizleri, uygun antrenman programlarÄ±yla Ã§ocuklarda ortalama %5-15 (1.5-4.5 ml/kg/dk) artÄ±ÅŸ saÄŸlanabileceÄŸini gÃ¶stermektedir. Bu artÄ±ÅŸ miktarÄ±:</p>
            <ul>
                <li>BaÅŸlangÄ±Ã§ fitness seviyesi</li>
                <li>Antrenman yoÄŸunluÄŸu ve sÃ¼resi</li>
                <li>MatÃ¼rasyon durumu</li>
                <li>Genetik faktÃ¶rler</li>
            </ul>
            <p>ile yakÄ±ndan iliÅŸkilidir.</p>
        </div>

        <!-- Notes for Slide 3 -->
        <div class="notes" id="notes-3" style="display: none;">
            <h3>ğŸ§¬ VOâ‚‚max BELÄ°RLEYÄ°CÄ° FAKTÃ–RLERÄ°</h3>
            
            <h4>ğŸ«€ Merkezi (Santral) FaktÃ¶rler</h4>
            <p>Merkezi faktÃ¶rler, oksijen transport sisteminin kardiyovaskÃ¼ler komponenetlerini iÃ§erir ve VOâ‚‚max'Ä±n yaklaÅŸÄ±k %70-85'ini belirler.</p>

            <h5>1. Maksimal Kardiyak Output (QÌ‡max)</h5>
            <p>En kritik belirleyici faktÃ¶rdÃ¼r. Elit dayanÄ±klÄ±lÄ±k sporcularÄ±nda 35-40 L/dk'ya ulaÅŸabilirken, sedanter bireylerde 15-20 L/dk civarÄ±ndadÄ±r.</p>
            <div class="formula-box">
                QÌ‡max = SVmax Ã— HRmax
            </div>
            <ul>
                <li><strong>Stroke Volume (SV):</strong> Ã‡ocuklarda 50-100 ml arasÄ±nda deÄŸiÅŸir</li>
                <li><strong>Maksimal Kalp HÄ±zÄ±:</strong> YaÅŸla ters orantÄ±lÄ± (220-yaÅŸ formÃ¼lÃ¼)</li>
                <li><strong>Frank-Starling MekanizmasÄ±:</strong> VenÃ¶z dÃ¶nÃ¼ÅŸ artÄ±ÅŸÄ±yla SV artÄ±ÅŸÄ±</li>
                <li><strong>Kontraktilite:</strong> MiyokardÄ±n kasÄ±lma gÃ¼cÃ¼</li>
            </ul>

            <h5>2. Oksijen TaÅŸÄ±ma Kapasitesi</h5>
            <ul>
                <li><strong>Hemoglobin Konsantrasyonu:</strong> 1 g Hb = 1.34 ml Oâ‚‚ taÅŸÄ±ma kapasitesi</li>
                <li><strong>Total Hemoglobin MiktarÄ±:</strong> VÃ¼cut boyutuyla orantÄ±lÄ± artÄ±ÅŸ</li>
                <li><strong>Kan Hacmi:</strong> Antrenmanla %10-15 artÄ±ÅŸ (plazma hacmi artÄ±ÅŸÄ±)</li>
                <li><strong>Hematokrit:</strong> Optimal deÄŸer %42-45 (viscosity-Oâ‚‚ taÅŸÄ±ma dengesi)</li>
            </ul>

            <h4>ğŸ’ª Periferik FaktÃ¶rler</h4>
            <p>Kas dÃ¼zeyindeki faktÃ¶rler, oksijen utilizasyonunu belirler ve VOâ‚‚max'Ä±n %15-30'unu oluÅŸturur.</p>

            <h5>1. Kas Lifi Kompozisyonu</h5>
            <ul>
                <li><strong>Tip I (YavaÅŸ KasÄ±lan) Lifler:</strong> YÃ¼ksek oksidatif kapasite</li>
                <li><strong>Tip IIa (HÄ±zlÄ± Oksidatif):</strong> Orta dÃ¼zey aerobik kapasite</li>
                <li><strong>Tip IIx (HÄ±zlÄ± Glikolitik):</strong> DÃ¼ÅŸÃ¼k aerobik kapasite</li>
                <li><strong>Fiber Type Shift:</strong> Antrenmanla IIx â†’ IIa dÃ¶nÃ¼ÅŸÃ¼mÃ¼</li>
            </ul>

            <h5>2. Mitokondriyal Adaptasyonlar</h5>
            <div class="highlight-box">
                <p><strong>Mitokondriyal Biogenesis MekanizmalarÄ±:</strong></p>
                <ul>
                    <li>PGC-1Î± aktivasyonu (master regulator)</li>
                    <li>Citrate synthase aktivitesi %20-100 artÄ±ÅŸ</li>
                    <li>Succinate dehydrogenase artÄ±ÅŸÄ±</li>
                    <li>Electron transport chain protein ekspresyonu</li>
                </ul>
            </div>

            <h5>3. Kapillarizasyon</h5>
            <ul>
                <li><strong>Kapiller/Fiber OranÄ±:</strong> Sedanter: 1.5, AntrenmanlÄ±: 2.5-3.0</li>
                <li><strong>Kapiller YoÄŸunluÄŸu:</strong> mmÂ² baÅŸÄ±na 300-600 kapiller</li>
                <li><strong>Diffusion Mesafesi:</strong> AzalmÄ±ÅŸ Oâ‚‚ diffusion distance</li>
                <li><strong>Transit Time:</strong> ArtmÄ±ÅŸ kapiller kan geÃ§iÅŸ sÃ¼resi</li>
            </ul>

            <h4>ğŸ§¬ Genetik FaktÃ¶rler (2024 GÃ¼ncellemesi)</h4>
            <p>VOâ‚‚max'Ä±n kalÄ±tsallÄ±k derecesi %40-50 arasÄ±ndadÄ±r. BazÄ± spesifik gen polimorfizmleri aerobik performansla iliÅŸkilendirilmiÅŸtir:</p>

            <ul>
                <li><strong>ACE I/D Polimorfizmi:</strong> I alleli dayanÄ±klÄ±lÄ±k avantajÄ± saÄŸlar</li>
                <li><strong>ACTN3 R577X:</strong> XX genotipi dayanÄ±klÄ±lÄ±k sporlarÄ±nda avantaj</li>
                <li><strong>MCT1 A1470T:</strong> Laktat transportu ve kullanÄ±mÄ±nÄ± etkiler</li>
                <li><strong>VEGF:</strong> Anjiogenesis ve kapillarizasyonu dÃ¼zenler</li>
                <li><strong>NRF2:</strong> Mitokondriyal biogenesis regÃ¼lasyonu</li>
            </ul>

            <h4>âš–ï¸ Ã‡ocuklarda Ã–zel Durumlar</h4>
            <p><strong>VÃ¼cut Boyutu ve Ã–lÃ§eklendirme:</strong></p>
            <ul>
                <li>Geometrik benzerlik teorisi</li>
                <li>Surface law (yÃ¼zey alanÄ±/kÃ¼tle oranÄ±)</li>
                <li>Allometrik Ã¶lÃ§eklendirme (kg^0.75)</li>
                <li>Maturity offset considerations</li>
            </ul>

            <p><strong>TermoregÃ¼lasyon FaktÃ¶rleri:</strong></p>
            <ul>
                <li>YÃ¼ksek yÃ¼zey alanÄ±/kÃ¼tle oranÄ±</li>
                <li>DÃ¼ÅŸÃ¼k ter Ã¼retim kapasitesi</li>
                <li>YÃ¼ksek kutanÃ¶z vasodilatasyon</li>
                <li>Metabolik heat production farklÄ±lÄ±klarÄ±</li>
            </ul>
        </div>

        <!-- Notes for Slide 9 -->
        <div class="notes" id="notes-9" style="display: none;">
            <h3>âš¡ YENÄ° EÄÄ°LÄ°MLER: HIIT VE Ä°NTERVAL ANTRENMAN</h3>
            
            <h4>ğŸ”¥ HIIT'in Ã‡ocuklarda Fizyolojik Etkileri</h4>
            <p>High-Intensity Interval Training (HIIT), son yÄ±llarda Ã§ocuk ve adolesanlarda aerobik gÃ¼Ã§ geliÅŸtirmede devrim niteliÄŸinde sonuÃ§lar gÃ¶stermiÅŸtir. 2023-2024 meta-analizleri, HIIT'in geleneksel sÃ¼rekli antrenmana Ã¼stÃ¼nlÃ¼ÄŸÃ¼nÃ¼ kanÄ±tlamÄ±ÅŸtÄ±r.</p>
            
            <div class="highlight-box">
                <h5>ğŸ“Š HIIT vs SÃ¼rekli Antrenman KarÅŸÄ±laÅŸtÄ±rmasÄ± (2024 Meta-Analiz):</h5>
                <ul>
                    <li><strong>VOâ‚‚max GeliÅŸimi:</strong> HIIT %18-25, SÃ¼rekli %8-12</li>
                    <li><strong>Zaman VerimliliÄŸi:</strong> HIIT 3x daha verimli</li>
                    <li><strong>Adherence Rate:</strong> HIIT %85, SÃ¼rekli %62</li>
                    <li><strong>Enjoyment Score:</strong> HIIT 8.2/10, SÃ¼rekli 5.8/10</li>
                </ul>
            </div>
            
            <h4>ğŸ§¬ MolekÃ¼ler ve HÃ¼cresel Adaptasyonlar</h4>
            <p>HIIT'in Ã§ocuklarda benzersiz adaptasyonlarÄ± son araÅŸtÄ±rmalarla detaylandÄ±rÄ±lmÄ±ÅŸtÄ±r:</p>
            
            <h5>1. Mitokondriyal Biogenez:</h5>
            <ul>
                <li><strong>PGC-1Î± Upregulation:</strong> %45-60 artÄ±ÅŸ (6 hafta HIIT)</li>
                <li><strong>Mitokondriyal Density:</strong> %35-50 artÄ±ÅŸ</li>
                <li><strong>Citrate Synthase Activity:</strong> %40-65 artÄ±ÅŸ</li>
                <li><strong>COX-IV Expression:</strong> %30-45 artÄ±ÅŸ</li>
            </ul>
            
            <h5>2. VaskÃ¼ler Adaptasyonlar:</h5>
            <ul>
                <li><strong>Kapiller Density:</strong> %25-35 artÄ±ÅŸ</li>
                <li><strong>Endotelyal Function:</strong> Flow-mediated dilation iyileÅŸmesi</li>
                <li><strong>Arteriyel Compliance:</strong> Pulse wave velocity dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                <li><strong>Nitric Oxide Bioavailability:</strong> %20-30 artÄ±ÅŸ</li>
            </ul>
            
            <h4>ğŸ¯ Ã‡ocuk-Spesifik HIIT Protokolleri</h4>
            <p>YaÅŸ grubuna gÃ¶re optimize edilmiÅŸ HIIT protokolleri:</p>
            
            <h5>â­ 6-8 YaÅŸ (Temel DÃ¼zey):</h5>
            <div class="formula-box">
                Protokol: 15sn Work : 45sn Rest<br>
                Ä°ntensity: %85-90 HRmax<br>
                Set SayÄ±sÄ±: 8-10 interval<br>
                Frekans: 2-3 gÃ¼n/hafta
            </div>
            
            <h5>â­ 9-11 YaÅŸ (Orta DÃ¼zey):</h5>
            <div class="formula-box">
                Protokol: 30sn Work : 90sn Rest<br>
                Ä°ntensity: %90-95 HRmax<br>
                Set SayÄ±sÄ±: 10-12 interval<br>
                Frekans: 3 gÃ¼n/hafta
            </div>
            
            <h5>â­ 12-14 YaÅŸ (Ä°leri DÃ¼zey):</h5>
            <div class="formula-box">
                Protokol: 4 dk Work : 3 dk Rest (4x4 NorveÃ§ Model)<br>
                Ä°ntensity: %90-95 HRmax<br>
                Set SayÄ±sÄ±: 4 interval<br>
                Frekans: 3 gÃ¼n/hafta
            </div>
            
            <h5>â­ 15+ YaÅŸ (Expert DÃ¼zey):</h5>
            <div class="formula-box">
                Protokol: Mixed (30sn-4dk intervals)<br>
                Ä°ntensity: %95-100 HRmax<br>
                Periodization: Periodize edilmiÅŸ yaklaÅŸÄ±m<br>
                Frekans: 3-4 gÃ¼n/hafta
            </div>
            
            <h4>ğŸ§  NÃ¶romuskÃ¼ler ve Kognitif Etkiler</h4>
            <p>HIIT'in Ã§ocuklarda sadece fiziksel deÄŸil, kognitif geliÅŸime de katkÄ±larÄ±:</p>
            
            <h5>1. Executive Function Enhancement:</h5>
            <ul>
                <li><strong>Working Memory:</strong> %15-20 geliÅŸim</li>
                <li><strong>Inhibitory Control:</strong> Stroop test performansÄ±nda iyileÅŸme</li>
                <li><strong>Cognitive Flexibility:</strong> Task switching hÄ±zÄ±nda artÄ±ÅŸ</li>
                <li><strong>Attention Span:</strong> SÃ¼rdÃ¼rÃ¼len dikkat sÃ¼resi artÄ±ÅŸÄ±</li>
            </ul>
            
            <h5>2. BDNF ve NÃ¶roplastisite:</h5>
            <ul>
                <li><strong>Brain-Derived Neurotrophic Factor:</strong> %25-40 artÄ±ÅŸ</li>
                <li><strong>Hipokampal VolÃ¼m:</strong> MRI studies ile doÄŸrulanmÄ±ÅŸ artÄ±ÅŸ</li>
                <li><strong>Prefrontal Cortex:</strong> Aktivasyon pattern deÄŸiÅŸimi</li>
                <li><strong>Memory Consolidation:</strong> Long-term memory iyileÅŸmesi</li>
            </ul>
            
            <h4>âš ï¸ HIIT'te GÃ¼venlik ve Dikkat Edilecekler</h4>
            <p><strong>Contraindications ve Risk FaktÃ¶rleri:</strong></p>
            <ul>
                <li><strong>Kardiyak Anomaliler:</strong> Detailed screening gerekli</li>
                <li><strong>AstÄ±m:</strong> Bronkospazm riski, inhaler standby</li>
                <li><strong>Ortopedik Problemler:</strong> Growth plate considerations</li>
                <li><strong>Diabetes:</strong> Hipoglisemi riski, close monitoring</li>
            </ul>
            
            <h4>ğŸ“ˆ Progressyon ve Monitoring</h4>
            <p>HIIT progressyonunda sistematik yaklaÅŸÄ±m:</p>
            
            <h5>1. Load Progression:</h5>
            <ul>
                <li><strong>1-2. Hafta:</strong> Volume adaptation</li>
                <li><strong>3-4. Hafta:</strong> Intensity increase</li>
                <li><strong>5-6. Hafta:</strong> Work:Rest ratio manipulation</li>
                <li><strong>7-8. Hafta:</strong> Deload ve recovery</li>
            </ul>
            
            <h5>2. Monitoring Parameters:</h5>
            <ul>
                <li><strong>Heart Rate Variability:</strong> Recovery gÃ¶stergesi</li>
                <li><strong>RPE Scales:</strong> Ã‡ocuk-dostu Borg scale</li>
                <li><strong>Performance Metrics:</strong> Time-to-exhaustion tests</li>
                <li><strong>Wellness Questionnaires:</strong> Sleep, mood, energy levels</li>
            </ul>
        </div>
        
        <!-- Notes for Slide 10 -->
        <div class="notes" id="notes-10" style="display: none;">
            <h3>âš–ï¸ CÄ°NSÄ°YET FARKLILIKLARI VE HORMONAL ETKÄ°LER</h3>
            
            <h4>ğŸš» Prepubertial DÃ¶nemde Cinsiyet FarklarÄ±</h4>
            <p>Puberte Ã¶ncesi dÃ¶nemde (Tanner Stage 1-2), erkek ve kÄ±z Ã§ocuklar arasÄ±nda aerobik kapasite farklarÄ± minimal dÃ¼zeydedir. Ancak 2023-2024 verilerine gÃ¶re subtle farklÄ±lÄ±klar gÃ¶zlenmektedir:</p>
            
            <h5>ğŸ“Š 6-10 YaÅŸ VOâ‚‚max DeÄŸerleri (ml/kg/dk):</h5>
            <div class="highlight-box">
                <ul>
                    <li><strong>Erkek Ã‡ocuklar:</strong> 48.2 Â± 5.8 ml/kg/dk</li>
                    <li><strong>KÄ±z Ã‡ocuklar:</strong> 46.9 Â± 5.2 ml/kg/dk</li>
                    <li><strong>Fark:</strong> %2.7 (istatistiksel olarak anlamlÄ± deÄŸil)</li>
                    <li><strong>Effect Size:</strong> d = 0.24 (small effect)</li>
                </ul>
            </div>
            
            <h4>ğŸ”„ Pubertal DÃ¶nemde Dramatik DeÄŸiÅŸimler</h4>
            <p>Puberte baÅŸlangÄ±cÄ± ile birlikte, hormon konsantrasyonlarÄ±ndaki deÄŸiÅŸimler aerobik kapasitede belirgin cinsiyet farklÄ±lÄ±klarÄ±na yol aÃ§ar:</p>
            
            <h5>âš¡ Pubertal Peak (11-14 yaÅŸ) DeÄŸerleri:</h5>
            <ul>
                <li><strong>Erkek Adolesanlar:</strong> 52.8 Â± 7.2 ml/kg/dk (%10 artÄ±ÅŸ)</li>
                <li><strong>KÄ±z Adolesanlar:</strong> 45.1 Â± 5.8 ml/kg/dk (%4 azalÄ±ÅŸ)</li>
                <li><strong>Cinsiyet Gap:</strong> %15.3 fark (p<0.001)</li>
                <li><strong>Effect Size:</strong> d = 1.18 (large effect)</li>
            </ul>
            
            <h4>ğŸ§¬ Hormonal Mekanizmalar</h4>
            <p>Cinsiyet farklÄ±lÄ±klarÄ±nda rol oynayan temel hormonal faktÃ¶rler:</p>
            
            <h5>1. Testosteron Etkiler:</h5>
            <ul>
                <li><strong>Kas KÃ¼tlesi ArtÄ±ÅŸÄ±:</strong> Lean body mass %25-40 artÄ±ÅŸ</li>
                <li><strong>Hemoglobin Konsantrasyonu:</strong> Oâ‚‚ transport kapasitesi artÄ±ÅŸÄ±</li>
                <li><strong>Kardiyak Output:</strong> Stroke volume ve kalp boyutu artÄ±ÅŸÄ±</li>
                <li><strong>Mitokondriyal Biogenez:</strong> Oxidative enzim aktivitesi artÄ±ÅŸÄ±</li>
            </ul>
            
            <h5>2. Ã–strojen Etkiler:</h5>
            <ul>
                <li><strong>YaÄŸ DaÄŸÄ±lÄ±mÄ±:</strong> Essential fat %12-15'e Ã§Ä±kÄ±ÅŸ</li>
                <li><strong>Iron Deficiency Risk:</strong> Menstrual losses</li>
                <li><strong>VOâ‚‚ Kinetics:</strong> Slower oxygen uptake kinetics</li>
                <li><strong>TermoregÃ¼lasyon:</strong> Menstrual cycle dependent variations</li>
            </ul>
            
            <h5>3. Growth Hormone & IGF-1:</h5>
            <ul>
                <li><strong>Pubertal Growth Spurt:</strong> Linear growth acceleration</li>
                <li><strong>Muscle Fiber Development:</strong> Type II fiber hypertrophy</li>
                <li><strong>Cardiac Development:</strong> Left ventricular mass artÄ±ÅŸÄ±</li>
                <li><strong>Metabolic Efficiency:</strong> Substrate utilization optimization</li>
            </ul>
            
            <h4>ğŸ”¬ Body Composition Changes</h4>
            <p>Puberte boyunca vÃ¼cut kompozisyonundaki deÄŸiÅŸimler aerobik performansÄ± direkt etkiler:</p>
            
            <h5>ğŸ“ˆ Erkek Adolesanlarda:</h5>
            <div class="formula-box">
                Lean Body Mass: +45-65% (10-18 yaÅŸ)<br>
                Body Fat %: 12-15% â†’ 8-12%<br>
                Muscle Mass: +42-58%<br>
                Bone Density: +40-50%
            </div>
            
            <h5>ğŸ“ˆ KÄ±z Adolesanlarda:</h5>
            <div class="formula-box">
                Lean Body Mass: +25-35% (10-18 yaÅŸ)<br>
                Body Fat %: 16-18% â†’ 20-25%<br>
                Muscle Mass: +20-30%<br>
                Bone Density: +35-45%
            </div>
            
            <h4>ğŸƒâ€â™€ï¸ Menstrual Cycle ve Performance</h4>
            <p>Menarche sonrasÄ± kÄ±z adolesanlarda menstrual cycle'Ä±n aerobik performans Ã¼zerindeki etkileri:</p>
            
            <h5>â° Cycle Phase Etkileri:</h5>
            <ul>
                <li><strong>Follicular Phase (1-14 gÃ¼n):</strong> Optimal aerobik performance</li>
                <li><strong>Ovulation (14-16 gÃ¼n):</strong> Core temperature elevation</li>
                <li><strong>Luteal Phase (16-28 gÃ¼n):</strong> %5-8 performance dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                <li><strong>Menstruation (1-5 gÃ¼n):</strong> Iron deficiency riski</li>
            </ul>
            
            <h5>ğŸ©¸ Iron Deficiency Anemia:</h5>
            <ul>
                <li><strong>Prevalence:</strong> Adolescent kÄ±zlarda %15-20</li>
                <li><strong>VOâ‚‚max Impact:</strong> %10-15 dÃ¼ÅŸÃ¼ÅŸ (severe cases)</li>
                <li><strong>Monitoring:</strong> Hemoglobin, hematocrit, ferritin levels</li>
                <li><strong>Intervention:</strong> Iron supplementation protocols</li>
            </ul>
            
            <h4>ğŸ¯ Cinsiyet-Spesifik Antrenman Stratejileri</h4>
            <p>Hormon profilleri ve fizyolojik farklÄ±lÄ±klara dayalÄ± antrenman yaklaÅŸÄ±mlarÄ±:</p>
            
            <h5>ğŸ‘¦ Erkek Adolesanlar Ä°Ã§in:</h5>
            <ul>
                <li><strong>YÃ¼ksek Ä°ntensity Tolerance:</strong> HIIT protocols daha agresif</li>
                <li><strong>Strength-Endurance Fusion:</strong> Resistance + aerobik kombinasyon</li>
                <li><strong>Recovery Optimization:</strong> Testosteron peaks (early morning training)</li>
                <li><strong>Progressive Overload:</strong> HÄ±zlÄ± adaptation capacity</li>
            </ul>
            
            <h5>ğŸ‘§ KÄ±z Adolesanlar Ä°Ã§in:</h5>
            <ul>
                <li><strong>Iron Status Monitoring:</strong> Regular blood work</li>
                <li><strong>Cycle-Based Periodization:</strong> Follicular phase iÃ§in high-intensity</li>
                <li><strong>Body Image Sensitivity:</strong> Positive reinforcement focus</li>
                <li><strong>Bone Health Priority:</strong> Weight-bearing activities emphasis</li>
            </ul>
            
            <h4>âš ï¸ Female Athlete Triad Riski</h4>
            <p>GenÃ§ kadÄ±n sporcularda Ã¶zel dikkat gerektiren durum:</p>
            
            <h5>ğŸ”º Triad Komponentleri:</h5>
            <ul>
                <li><strong>Energy Availability:</strong> <30 kcal/kg LBM/day</li>
                <li><strong>Menstrual Dysfunction:</strong> Oligomenore/amenore</li>
                <li><strong>Bone Health:</strong> DÃ¼ÅŸÃ¼k bone mineral density</li>
            </ul>
            
            <h5>âš ï¸ Screening ve MÃ¼dahale:</h5>
            <ul>
                <li><strong>Nutritional Assessment:</strong> Energy intake vs expenditure</li>
                <li><strong>Menstrual History:</strong> Cycle regularity tracking</li>
                <li><strong>DEXA Scan:</strong> Bone density monitoring</li>
                <li><strong>Multidisciplinary Approach:</strong> Physician, dietitian, psychologist</li>
            </ul>
        </div>
        
        <!-- Notes for Slide 11 -->
        <div class="notes" id="notes-11" style="display: none;">
            <h3>ğŸŒ¡ï¸ Ã‡EVREsel FAKTÃ–RLER VE ADAPTASYON</h3>
            
            <h4>ğŸ”¥ SÄ±caklÄ±k ve TermoregÃ¼lasyon</h4>
            <p>Ã‡ocuklarda termoregÃ¼lasyon kapasitesi yetiÅŸkinlerden farklÄ±dÄ±r ve aerobik performansÄ± Ã¶nemli Ã¶lÃ§Ã¼de etkiler. 2024 klimatoloji Ã§alÄ±ÅŸmalarÄ±, artan sÄ±caklÄ±klarÄ±n pediatrik popÃ¼lasyonda daha fazla risk oluÅŸturduÄŸunu gÃ¶stermektedir.</p>
            
            <h5>ğŸŒ¡ï¸ Ã‡ocuklarda TermoregÃ¼lasyon Ã–zellikleri:</h5>
            <div class="highlight-box">
                <ul>
                    <li><strong>YÃ¼zey AlanÄ±/KÃ¼tle OranÄ±:</strong> YetiÅŸkinlerin 2.5 katÄ±</li>
                    <li><strong>Ter Ãœretim Kapasitesi:</strong> %50-60 daha dÃ¼ÅŸÃ¼k</li>
                    <li><strong>Ter Kompozisyonu:</strong> YÃ¼ksek Na+ kaybÄ±</li>
                    <li><strong>Vasomotor Response:</strong> Daha yavaÅŸ adaptasyon</li>
                </ul>
            </div>
            
            <h5>ğŸ“Š SÄ±caklÄ±ÄŸa BaÄŸlÄ± VOâ‚‚max DeÄŸiÅŸimleri:</h5>
            <ul>
                <li><strong>20Â°C (Optimal):</strong> Baseline VOâ‚‚max (100%)</li>
                <li><strong>25Â°C:</strong> %2-3 dÃ¼ÅŸÃ¼ÅŸ</li>
                <li><strong>30Â°C:</strong> %5-8 dÃ¼ÅŸÃ¼ÅŸ</li>
                <li><strong>35Â°C:</strong> %12-18 dÃ¼ÅŸÃ¼ÅŸ (risk zonu)</li>
                <li><strong>40Â°C+:</strong> %20-25 dÃ¼ÅŸÃ¼ÅŸ (kritik durum)</li>
            </ul>
            
            <h4>â„ï¸ SoÄŸuk Ortam AdaptasyonlarÄ±</h4>
            <p>SoÄŸuk ortamlarda Ã§ocuklarda unique adaptasyon mekanizmalarÄ±:</p>
            
            <h5>ğŸ§Š Cold-Induced Adaptations:</h5>
            <ul>
                <li><strong>Shivering Thermogenesis:</strong> %15-20 daha yÃ¼ksek metabolic cost</li>
                <li><strong>Non-Shivering Thermogenesis:</strong> Brown adipose tissue aktivasyonu</li>
                <li><strong>Peripheral Vasoconstriction:</strong> Extremity blood flow azalÄ±ÅŸÄ±</li>
                <li><strong>Substrate Shifting:</strong> Fat oxidation artÄ±ÅŸÄ±</li>
            </ul>
            
            <h5>â„ï¸ SoÄŸuk Ortam VOâ‚‚max Etkileri:</h5>
            <ul>
                <li><strong>0-5Â°C:</strong> %3-5 artÄ±ÅŸ (optimal Oâ‚‚ solubility)</li>
                <li><strong>-5-0Â°C:</strong> Baseline performance</li>
                <li><strong>-10--5Â°C:</strong> %5-8 dÃ¼ÅŸÃ¼ÅŸ (thermoregulatory cost)</li>
                <li><strong><-10Â°C:</strong> %15+ dÃ¼ÅŸÃ¼ÅŸ (frostbite riski)</li>
            </ul>
            
            <h4>â›°ï¸ YÃ¼ksek Ä°rtifa (Altitude) Etkileri</h4>
            <p>YÃ¼ksek irtifanÄ±n Ã§ocuklarda aerobik kapasite Ã¼zerindeki etkileri yaÅŸa baÄŸlÄ± deÄŸiÅŸkenlik gÃ¶sterir:</p>
            
            <h5>ğŸ”ï¸ Ä°rtifa-Spesifik VOâ‚‚max DeÄŸiÅŸimleri:</h5>
            <div class="formula-box">
                VOâ‚‚max Reduction = 6.3% Ã— (Altitude in km)<br>
                Ã‡ocuklarda multiplier: 1.2-1.4x
            </div>
            
            <h5>ğŸ“ˆ Ä°rtifa Kademeleri ve Etkiler:</h5>
            <ul>
                <li><strong>Sea Level - 1500m:</strong> Minimal etki (%0-2)</li>
                <li><strong>1500-3000m:</strong> %5-12 VOâ‚‚max dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                <li><strong>3000-4500m:</strong> %15-25 dÃ¼ÅŸÃ¼ÅŸ (acclimatization gerekli)</li>
                <li><strong>4500m+:</strong> %25+ dÃ¼ÅŸÃ¼ÅŸ (kritik yÃ¼kseklik)</li>
            </ul>
            
            <h5>ğŸ”„ Altitude Acclimatization Process:</h5>
            <ul>
                <li><strong>1-3 GÃ¼n:</strong> Hipoksik ventilatory response artÄ±ÅŸÄ±</li>
                <li><strong>1 Hafta:</strong> Kardiyak output kompanzasyonu</li>
                <li><strong>2-3 Hafta:</strong> Hemoglobin konsantrasyon artÄ±ÅŸÄ±</li>
                <li><strong>4-6 Hafta:</strong> Mitokondriyal adaptasyonlar</li>
            </ul>
            
            <h4>ğŸ’¨ Hava Kalitesi ve Kirlilik</h4>
            <p>2024 WHO raporlarÄ±na gÃ¶re, hava kirliliÄŸi Ã§ocuklarda aerobik kapasiteyi ciddi ÅŸekilde etkiliyor:</p>
            
            <h5>ğŸŒ«ï¸ Kirlilik Parametreleri ve Etkiler:</h5>
            <ul>
                <li><strong>PM2.5 >35 Î¼g/mÂ³:</strong> %8-12 VOâ‚‚max dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                <li><strong>PM10 >50 Î¼g/mÂ³:</strong> %5-8 performans kaybÄ±</li>
                <li><strong>NOâ‚‚ >40 Î¼g/mÂ³:</strong> Respiratory function compromise</li>
                <li><strong>Oâ‚ƒ >120 Î¼g/mÂ³:</strong> Airways reactivity artÄ±ÅŸÄ±</li>
            </ul>
            
            <h5>ğŸš¨ Hava Kalitesi Ã–nlemleri:</h5>
            <ul>
                <li><strong>AQI <50 (Ä°yi):</strong> Normal aktivite</li>
                <li><strong>AQI 51-100 (Orta):</strong> Hassas gruplar dikkatli</li>
                <li><strong>AQI 101-150 (SaÄŸlÄ±ksÄ±z):</strong> AÃ§Ä±k hava aktivitesi sÄ±nÄ±rlÄ±</li>
                <li><strong>AQI >150:</strong> Outdoor exercise contraindication</li>
            </ul>
            
            <h4>ğŸ’§ Hidrasyon ve Elektrolit Balance</h4>
            <p>Ã‡ocuklarda sÄ±vÄ± homeostasisinin aerobik performansa etkisi:</p>
            
            <h5>ğŸ’¦ Dehydration Effects:</h5>
            <div class="highlight-box">
                <ul>
                    <li><strong>%2 SÄ±vÄ± KaybÄ±:</strong> %10-15 aerobik performance dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                    <li><strong>%3 SÄ±vÄ± KaybÄ±:</strong> TermoregÃ¼lasyon kompromisi</li>
                    <li><strong>%4 SÄ±vÄ± KaybÄ±:</strong> Heat illness riski</li>
                    <li><strong>%5+ SÄ±vÄ± KaybÄ±:</strong> Medical emergency</li>
                </ul>
            </div>
            
            <h5>âš–ï¸ Elektrolit Requirements (per hour exercise):</h5>
            <ul>
                <li><strong>Sodium:</strong> 200-300 mg/L replacement drink</li>
                <li><strong>Potassium:</strong> 150-250 mg/L</li>
                <li><strong>Magnesium:</strong> 50-100 mg/L</li>
                <li><strong>Chloride:</strong> 300-500 mg/L</li>
            </ul>
            
            <h4>ğŸŒ Ä°klim DeÄŸiÅŸikliÄŸi Etkileri</h4>
            <p>2024 IPCC raporuna gÃ¶re, iklim deÄŸiÅŸikliÄŸinin Ã§ocuk sporcu saÄŸlÄ±ÄŸÄ± Ã¼zerindeki projektÃ¶rleri:</p>
            
            <h5>ğŸ“ˆ Gelecek ProjeksiyonlarÄ± (2030-2050):</h5>
            <ul>
                <li><strong>Extreme Heat Days:</strong> %40-60 artÄ±ÅŸ bekleniyor</li>
                <li><strong>Heat Index >40Â°C:</strong> Exercise contraindication gÃ¼nleri artÄ±ÅŸÄ±</li>
                <li><strong>Indoor Training Necessity:</strong> %25-35 daha fazla</li>
                <li><strong>AC Energy Cost:</strong> Sports facilities iÃ§in %200+ artÄ±ÅŸ</li>
            </ul>
            
            <h5>ğŸ¯ Adaptation Strategies:</h5>
            <ul>
                <li><strong>Heat Acclimatization Protocols:</strong> Gradual exposure programs</li>
                <li><strong>Cooling Strategies:</strong> Pre-cooling, per-cooling, post-cooling</li>
                <li><strong>Scheduling Modifications:</strong> Early morning/late evening training</li>
                <li><strong>Technology Integration:</strong> Environmental monitoring systems</li>
            </ul>
        </div>
        
        <!-- Notes for Slide 12 -->
        <div class="notes" id="notes-12" style="display: none;">
            <h3>ğŸ¦  COVID-19 PANDEMÄ°SÄ°NÄ°N ETKÄ°LERÄ°</h3>
            
            <h4>ğŸ“Š Pandeminin Global Ã‡ocuk Fitness Ãœzerindeki Etkisi</h4>
            <p>COVID-19 pandemisi, Ã§ocuk ve adolesanlarda aerobik kapasitede unprecedented dÃ¼ÅŸÃ¼ÅŸlere neden olmuÅŸtur. 2020-2024 boylamsal Ã§alÄ±ÅŸmalar, bu etkinin boyutunu net ÅŸekilde ortaya koymuÅŸtur.</p>
            
            <h5>ğŸ“‰ Pandemi Ã–ncesi vs Pandemi SonrasÄ± VOâ‚‚max DeÄŸerleri:</h5>
            <div class="highlight-box">
                <h6>ğŸ”¸ 6-10 YaÅŸ Grubu:</h6>
                <ul>
                    <li><strong>2019 (Pre-COVID):</strong> 47.8 Â± 5.6 ml/kg/dk</li>
                    <li><strong>2021 (During COVID):</strong> 43.2 Â± 5.8 ml/kg/dk (-9.6%)</li>
                    <li><strong>2023 (Recovery Period):</strong> 45.1 Â± 5.4 ml/kg/dk (-5.6%)</li>
                    <li><strong>Effect Size:</strong> d = 0.82 (large effect)</li>
                </ul>
                
                <h6>ğŸ”¸ 11-14 YaÅŸ Grubu:</h6>
                <ul>
                    <li><strong>2019 (Pre-COVID):</strong> 49.2 Â± 6.8 ml/kg/dk</li>
                    <li><strong>2021 (During COVID):</strong> 42.8 Â± 6.2 ml/kg/dk (-13.0%)</li>
                    <li><strong>2023 (Recovery Period):</strong> 46.3 Â± 6.1 ml/kg/dk (-5.9%)</li>
                    <li><strong>Effect Size:</strong> d = 0.96 (large effect)</li>
                </ul>
            </div>
            
            <h4>ğŸ  Lockdown'un Fizyolojik SonuÃ§larÄ±</h4>
            <p>Evde kalma zorunluluÄŸu, Ã§ocuklarda multiple fizyolojik sistemlerde olumsuz deÄŸiÅŸiklikler yaratmÄ±ÅŸtÄ±r:</p>
            
            <h5>ğŸ’ª KardiyovaskÃ¼ler Sistem Etkileri:</h5>
            <ul>
                <li><strong>Resting Heart Rate:</strong> %8-12 artÄ±ÅŸ (deconditioning)</li>
                <li><strong>Blood Pressure:</strong> Systolic %5-8 artÄ±ÅŸ</li>
                <li><strong>Heart Rate Variability:</strong> %15-20 dÃ¼ÅŸÃ¼ÅŸ (autonomic dysfunction)</li>
                <li><strong>Endotelyal Function:</strong> Flow-mediated dilation bozulmasÄ±</li>
            </ul>
            
            <h5>ğŸ¦´ Muskuloskeletal Sistem Etkileri:</h5>
            <ul>
                <li><strong>Muscle Mass Loss:</strong> %5-12 quadriceps muscle atrophy</li>
                <li><strong>Bone Density:</strong> %3-7 dÃ¼ÅŸÃ¼ÅŸ (weight-bearing activity eksikliÄŸi)</li>
                <li><strong>Flexibility:</strong> %10-18 range of motion kaybÄ±</li>
                <li><strong>Core Stability:</strong> Postural control bozulmasÄ±</li>
            </ul>
            
            <h5>ğŸ§  Metabolik ve Endokrin Etkileri:</h5>
            <ul>
                <li><strong>Insulin Resistance:</strong> HOMA-IR deÄŸerlerinde %15-25 artÄ±ÅŸ</li>
                <li><strong>Lipid Profile:</strong> LDL artÄ±ÅŸÄ±, HDL azalÄ±ÅŸÄ±</li>
                <li><strong>Inflammatory Markers:</strong> CRP, IL-6 elevation</li>
                <li><strong>Cortisol Levels:</strong> Chronic stress response patterns</li>
            </ul>
            
            <h4>ğŸ“± Dijital Sedentarizm ArtÄ±ÅŸÄ±</h4>
            <p>Pandemi dÃ¶neminde screen time'da dramtik artÄ±ÅŸlar gÃ¶zlenmiÅŸtir:</p>
            
            <h5>â° Screen Time DeÄŸiÅŸimleri:</h5>
            <div class="formula-box">
                Pre-COVID: 2.4 Â± 1.2 saat/gÃ¼n<br>
                During COVID: 7.8 Â± 2.6 saat/gÃ¼n (+225%)<br>
                Post-COVID (2023): 5.2 Â± 2.1 saat/gÃ¼n (+117%)
            </div>
            
            <h5>ğŸ“º Digital Device Usage Breakdown:</h5>
            <ul>
                <li><strong>Smartphones:</strong> 3.2 saat/gÃ¼n (pre: 1.1 saat)</li>
                <li><strong>Computer/Tablet:</strong> 2.8 saat/gÃ¼n (educational)</li>
                <li><strong>TV/Streaming:</strong> 1.8 saat/gÃ¼n (entertainment)</li>
                <li><strong>Gaming:</strong> 1.6 saat/gÃ¼n (social interaction)</li>
            </ul>
            
            <h4>ğŸƒâ€â™‚ï¸ Home-Based Exercise Interventions</h4>
            <p>Pandemi dÃ¶neminde geliÅŸtirilen ev-bazlÄ± egzersiz programlarÄ±nÄ±n etkinliÄŸi:</p>
            
            <h5>â­ Successful Home Exercise Models:</h5>
            
            <h6>1. Virtual Group Classes:</h6>
            <ul>
                <li><strong>Format:</strong> Live-streamed 45-60 min sessions</li>
                <li><strong>Frequency:</strong> 3-4 sessions/hafta</li>
                <li><strong>Effectiveness:</strong> %12-18 VOâ‚‚max improvement</li>
                <li><strong>Adherence Rate:</strong> %68-75</li>
            </ul>
            
            <h6>2. App-Based Programs:</h6>
            <ul>
                <li><strong>Gamification Elements:</strong> Points, badges, leaderboards</li>
                <li><strong>Progress Tracking:</strong> Activity monitoring, goal setting</li>
                <li><strong>Social Features:</strong> Peer challenges, family involvement</li>
                <li><strong>Effectiveness:</strong> %8-14 aerobik improvement</li>
            </ul>
            
            <h6>3. Family-Based Activities:</h6>
            <ul>
                <li><strong>Walking/Jogging:</strong> Neighborhood circuits</li>
                <li><strong>Cycling:</strong> Safe outdoor alternatives</li>
                <li><strong>Home Circuit Training:</strong> Bodyweight exercises</li>
                <li><strong>Dance Programs:</strong> High adherence, enjoyable</li>
            </ul>
            
            <h4>ğŸ’‰ Post-COVID Syndrome (Long COVID) Pediatrik Etkileri</h4>
            <p>Long COVID Ã§ocuklarda aerobik kapasiteyi uzun dÃ¶nem etkileyebilmektedir:</p>
            
            <h5>ğŸ” Long COVID Prevalence:</h5>
            <ul>
                <li><strong>Ã‡ocuk PopÃ¼lasyonunda:</strong> %2-14 (Ã§alÄ±ÅŸmaya gÃ¶re deÄŸiÅŸken)</li>
                <li><strong>Exercise Intolerance:</strong> %25-40 (long COVID cases)</li>
                <li><strong>Fatigue Symptoms:</strong> %60-80</li>
                <li><strong>Dyspnea on Exertion:</strong> %30-50</li>
            </ul>
            
            <h5>ğŸ« Cardiopulmonary Sequelae:</h5>
            <ul>
                <li><strong>Myocarditis Risk:</strong> %0.1-0.5 (rare but serious)</li>
                <li><strong>POTS (Postural Tachycardia):</strong> %5-8</li>
                <li><strong>Pulmonary Function:</strong> %5-10 FEV1 reduction</li>
                <li><strong>Exercise Capacity:</strong> %15-25 VOâ‚‚max reduction</li>
            </ul>
            
            <h4>ğŸ¯ Recovery ve Rehabilitation Strategies</h4>
            <p>Post-COVID aerobik kapasite recovery iÃ§in evidence-based yaklaÅŸÄ±mlar:</p>
            
            <h5>ğŸ“ˆ Progressive Return-to-Exercise Protocol:</h5>
            <div class="highlight-box">
                <p><strong>Stage 1 (1-2 hafta):</strong></p>
                <ul>
                    <li>Light activity: Walking, stretching</li>
                    <li>Duration: 15-30 min</li>
                    <li>Intensity: <70% HRmax</li>
                </ul>
                <p><strong>Stage 2 (2-4 hafta):</strong></p>
                <ul>
                    <li>Moderate activity: Jogging, cycling</li>
                    <li>Duration: 30-45 min</li>
                    <li>Intensity: 70-80% HRmax</li>
                </ul>
                <p><strong>Stage 3 (4+ hafta):</strong></p>
                <ul>
                    <li>Sport-specific training</li>
                    <li>Duration: 45-60 min</li>
                    <li>Intensity: 80-90% HRmax</li>
                </ul>
            </div>
            
            <h4>ğŸ“š Pandemi DÃ¶neminden Ã‡Ä±karÄ±lan Dersler</h4>
            <p>COVID-19 deneyiminden pediatrik exercise science iÃ§in Ã¶nemli insights:</p>
            
            <h5>âœ… Positive Outcomes:</h5>
            <ul>
                <li><strong>Technology Integration:</strong> Digital fitness tools geliÅŸimi</li>
                <li><strong>Family Involvement:</strong> Aile-bazlÄ± aktivite artÄ±ÅŸÄ±</li>
                <li><strong>Flexibility in Programming:</strong> Adaptable exercise models</li>
                <li><strong>Mental Health Awareness:</strong> Exercise-mood connection recognition</li>
            </ul>
            
            <h5>âš ï¸ Challenges ve Lessons:</h5>
            <ul>
                <li><strong>Health Disparities:</strong> Socioeconomic gaps widening</li>
                <li><strong>Screen Time Management:</strong> Balance necessity</li>
                <li><strong>Social Isolation:</strong> Peer interaction importance</li>
                <li><strong>Infrastructure Needs:</strong> Community fitness facility investments</li>
            </ul>
            
            <h4>ğŸ”® Future Pandemic Preparedness</h4>
            <p>Gelecekteki pandemic scenarios iÃ§in Ã§ocuk fitness preservation strategies:</p>
            
            <h5>ğŸ›¡ï¸ Preparedness Strategies:</h5>
            <ul>
                <li><strong>Hybrid Exercise Models:</strong> Online-offline kombinasyonlarÄ±</li>
                <li><strong>Emergency Fitness Protocols:</strong> Rapid deployment capabilities</li>
                <li><strong>Technology Infrastructure:</strong> Accessible digital platforms</li>
                <li><strong>Community Partnerships:</strong> School-family-healthcare collaboration</li>
            </ul>
        </div>

        <!-- Notes for Slide 4 -->
        <div class="notes" id="notes-4" style="display: none;">
            <h3>âš–ï¸ MEKANÄ°K VERÄ°MLÄ°LÄ°K VE YAÅ</h3>
            
            <h4>ğŸ”§ Mekanik Verimlilik KavramÄ±</h4>
            <p>Mekanik verimlilik, yapÄ±lan mekanik iÅŸin harcanan metabolik enerjiye oranÄ±dÄ±r. Ã‡ocuklarda bu oran yetiÅŸkinlere gÃ¶re Ã¶nemli Ã¶lÃ§Ã¼de dÃ¼ÅŸÃ¼ktÃ¼r, bu da aynÄ± iÅŸ yÃ¼kÃ¼nde daha fazla enerji harcadÄ±klarÄ± anlamÄ±na gelir.</p>

            <div class="formula-box">
                Mekanik Verimlilik (%) = (Mekanik Ä°ÅŸ / Metabolik Enerji Maliyeti) Ã— 100
            </div>

            <h5>ğŸ“Š YaÅŸa GÃ¶re Verimlilik DeÄŸerleri (2024 Meta-Analiz):</h5>
            <ul>
                <li><strong>6-8 yaÅŸ:</strong> %12-15 (en dÃ¼ÅŸÃ¼k verimlilik)</li>
                <li><strong>9-11 yaÅŸ:</strong> %15-18 (progressive geliÅŸim)</li>
                <li><strong>12-14 yaÅŸ:</strong> %18-22 (hÄ±zlÄ± iyileÅŸme)</li>
                <li><strong>15-17 yaÅŸ:</strong> %20-25 (yetiÅŸkin seviyesine yaklaÅŸÄ±m)</li>
                <li><strong>YetiÅŸkin:</strong> %23-25 (optimal verimlilik)</li>
            </ul>

            <h4>ğŸƒâ€â™‚ï¸ KoÅŸu Ekonomisi FaktÃ¶rleri</h4>
            <p>Ã‡ocuklarda koÅŸu ekonomisinin dÃ¼ÅŸÃ¼k olmasÄ±nÄ±n nedenleri multifaktÃ¶riyeldir:</p>

            <h5>1. Biyomekanik FaktÃ¶rler</h5>
            <ul>
                <li><strong>AdÄ±m FrekansÄ±:</strong> Ã‡ocuklarda 180-200 adÄ±m/dk (yetiÅŸkin: 160-180)</li>
                <li><strong>AdÄ±m UzunluÄŸu:</strong> Bacak boyuyla sÄ±nÄ±rlÄ±, suboptimal stride length</li>
                <li><strong>Vertikal SalÄ±nÄ±m:</strong> Fazla dikey hareket, enerji kaybÄ±</li>
                <li><strong>Ground Contact Time:</strong> Uzun temas sÃ¼resi, dÃ¼ÅŸÃ¼k elastik enerji kullanÄ±mÄ±</li>
            </ul>

            <h5>2. NÃ¶romÃ¼skÃ¼ler FaktÃ¶rler</h5>
            <div class="highlight-box">
                <ul>
                    <li><strong>Ko-kontraksiyon:</strong> Agonist-antagonist kas gruplarÄ±nÄ±n aÅŸÄ±rÄ± aktivasyonu</li>
                    <li><strong>Motor Unit Recruitment:</strong> Ä°nefficient motor unit firing patterns</li>
                    <li><strong>Koordinasyon:</strong> Ä°mmatÃ¼r inter-limb coordination</li>
                    <li><strong>Propriosepsiyon:</strong> GeliÅŸmemiÅŸ kinesthetic awareness</li>
                </ul>
            </div>

            <h5>3. Metabolik FaktÃ¶rler</h5>
            <ul>
                <li><strong>YÃ¼ksek Metabolik Rate:</strong> BÃ¼yÃ¼me iÃ§in ekstra enerji gereksinimi</li>
                <li><strong>Substrat KullanÄ±mÄ±:</strong> YaÄŸ oksidasyonuna baÄŸÄ±mlÄ±lÄ±k (dÃ¼ÅŸÃ¼k Oâ‚‚ verimi)</li>
                <li><strong>Mitokondriyal Verimlilik:</strong> P/O oranÄ±nda yaÅŸla birlikte geliÅŸim</li>
                <li><strong>TermoregÃ¼lasyon Maliyeti:</strong> YÃ¼ksek Ä±sÄ± Ã¼retimi ve kaybÄ±</li>
            </ul>

            <h4>âš ï¸ DÃ¼ÅŸÃ¼k VerimliliÄŸin Pratik SonuÃ§larÄ±</h4>
            <p>Ã‡ocuklarda mekanik verimliliÄŸin dÃ¼ÅŸÃ¼k olmasÄ± ÅŸu pratik sonuÃ§lara yol aÃ§ar:</p>
            <ul>
                <li><strong>YÃ¼ksek Oâ‚‚ Maliyeti:</strong> AynÄ± hÄ±zda %20-30 daha fazla VOâ‚‚</li>
                <li><strong>Erken Yorgunluk:</strong> Submaksimal yÃ¼klerde hÄ±zlÄ± tÃ¼kenme</li>
                <li><strong>DÃ¼ÅŸÃ¼k Ekonomi:</strong> Uzun mesafe performansÄ±nda dezavantaj</li>
                <li><strong>IsÄ± Stresi Riski:</strong> ArtmÄ±ÅŸ metabolik Ä±sÄ± Ã¼retimi</li>
            </ul>

            <h4>ğŸ¯ Verimlilik GeliÅŸtirme Stratejileri</h4>
            <p><strong>KanÄ±ta DayalÄ± Ä°yileÅŸtirme YaklaÅŸÄ±mlarÄ±:</strong></p>

            <h5>1. Teknik Antrenman</h5>
            <ul>
                <li>KoÅŸu mekaniÄŸi drilleri (A-skip, B-skip, high knees)</li>
                <li>Video analizi ve feedback</li>
                <li>Cadence training (metronom kullanÄ±mÄ±)</li>
                <li>Posture ve core stability Ã§alÄ±ÅŸmalarÄ±</li>
            </ul>

            <h5>2. Koordinasyon GeliÅŸtirme</h5>
            <ul>
                <li>Plyometric exercises (yaÅŸa uygun)</li>
                <li>Agility ladder drills</li>
                <li>Balance ve propriosepsiyon egzersizleri</li>
                <li>Multi-directional movement patterns</li>
            </ul>

            <h5>3. Progressive Overload</h5>
            <ul>
                <li>Kademeli mesafe artÄ±ÅŸÄ±</li>
                <li>Tempo runs (kontrollÃ¼ hÄ±z)</li>
                <li>Fartlek training (hÄ±z deÄŸiÅŸimleri)</li>
                <li>Hill training (ekonomi geliÅŸtirme)</li>
            </ul>

            <h4>ğŸ“ˆ Longitudinal GeliÅŸim Patternleri</h4>
            <p>Boylamsal Ã§alÄ±ÅŸmalar, mekanik verimliliÄŸin geliÅŸiminde kritik dÃ¶nemleri ortaya koymaktadÄ±r:</p>
            <ul>
                <li><strong>6-8 yaÅŸ:</strong> Temel hareket becerileri kazanÄ±mÄ±</li>
                <li><strong>9-11 yaÅŸ:</strong> Koordinasyon penceresi (skill acquisition)</li>
                <li><strong>12-14 yaÅŸ:</strong> PHV dÃ¶neminde geÃ§ici bozulma</li>
                <li><strong>15+ yaÅŸ:</strong> Adult pattern'e geÃ§iÅŸ</li>
            </ul>
        </div>

        <!-- Notes for Slide 5 -->
        <div class="notes" id="notes-5" style="display: none;">
            <h3>ğŸ“ˆ VOâ‚‚max DEÄERLENDÄ°RME YÃ–NTEMLERÄ°</h3>
            
            <h4>ğŸ† AltÄ±n Standart: Kardiyopulmoner Egzersiz Testi (CPET)</h4>
            <p>Laboraturar ortamÄ±nda gerÃ§ekleÅŸtirilen CPET, VOâ‚‚max Ã¶lÃ§Ã¼mÃ¼nde en doÄŸru ve gÃ¼venilir yÃ¶ntemdir. Ã–zellikle araÅŸtÄ±rma amaÃ§lÄ± Ã§alÄ±ÅŸmalarda ve klinik deÄŸerlendirmelerde tercih edilir.</p>

            <h5>ğŸ”¬ CPET Komponenetleri:</h5>
            <ul>
                <li><strong>Breath-by-breath Gaz Analizi:</strong> SÃ¼rekli VOâ‚‚ ve VCOâ‚‚ Ã¶lÃ§Ã¼mÃ¼</li>
                <li><strong>12-Lead EKG:</strong> Kardiyak aritmia ve iskemi monitÃ¶rizasyonu</li>
                <li><strong>Kan BasÄ±ncÄ± Takibi:</strong> Hemodinamik yanÄ±t deÄŸerlendirmesi</li>
                <li><strong>Pulse Oksimetri:</strong> Arteriyel oksijen satÃ¼rasyon takibi</li>
                <li><strong>Laktat Analizi:</strong> Metabolik eÅŸik belirlenmesi</li>
            </ul>

            <h5>ğŸ“‹ Ã‡ocuklar Ä°Ã§in Test Protokolleri:</h5>
            <div class="highlight-box">
                <p><strong>McMaster ProtokolÃ¼ (Cycle):</strong></p>
                <ul>
                    <li>BaÅŸlangÄ±Ã§: 15W (kÃ¼Ã§Ã¼k Ã§ocuklar iÃ§in 0W)</li>
                    <li>ArtÄ±ÅŸ: Her dakikada 15W</li>
                    <li>Test sÃ¼resi: 8-12 dakika optimal</li>
                </ul>
                <p><strong>Balke ProtokolÃ¼ (Treadmill):</strong></p>
                <ul>
                    <li>HÄ±z: Sabit (4-6 mph)</li>
                    <li>EÄŸim: %2'den baÅŸlayarak her 2 dk'da %2 artÄ±ÅŸ</li>
                    <li>Ã‡ocuk dostu modifikasyonlar</li>
                </ul>
            </div>

            <h4>ğŸƒâ€â™‚ï¸ Saha Testleri (Field Tests)</h4>
            <p>Saha testleri, geniÅŸ popÃ¼lasyonlar iÃ§in pratik, ekonomik ve implement edilebilir alternatifler sunar. 2023-2024 validasyon Ã§alÄ±ÅŸmalarÄ± ile gÃ¼ncellenen korelasyon deÄŸerleri:</p>

            <h5>â­ PACER Test (20m Shuttle Run):</h5>
            <ul>
                <li><strong>Korelasyon:</strong> r = 0.71-0.84 (laboratuvar CPET ile)</li>
                <li><strong>Test-Retest GÃ¼venilirlik:</strong> r = 0.89-0.98</li>
                <li><strong>YaÅŸ AralÄ±ÄŸÄ±:</strong> 6-17 yaÅŸ iÃ§in validate</li>
                <li><strong>Tahmini Formula:</strong> VOâ‚‚max = 31.025 + 3.238Ã—(speed) - 3.248Ã—(age) + 0.1536Ã—(speedÃ—age)</li>
            </ul>

            <h5>ğŸ“Š DiÄŸer Saha Testleri:</h5>
            <ul>
                <li><strong>1 Mil KoÅŸu:</strong> r = 0.65-0.78, Ã¶zellikle >10 yaÅŸ iÃ§in uygun</li>
                <li><strong>Step Test (2024):</strong> r = 0.52-0.67, yeni pediatrik protokoller</li>
                <li><strong>Yo-Yo Intermittent Test:</strong> r = 0.75-0.82, spor branÅŸlarÄ±na Ã¶zel</li>
                <li><strong>Cooper 12-dakika KoÅŸu:</strong> r = 0.68-0.79, motivasyon faktÃ¶rÃ¼ yÃ¼ksek</li>
            </ul>

            <h4>ğŸ“± Modern Teknolojik YaklaÅŸÄ±mlar</h4>
            <p>2024'te teknolojik geliÅŸmelerle birlikte yeni deÄŸerlendirme araÃ§larÄ± geliÅŸtirilmiÅŸtir:</p>

            <h5>1. Wearable Technology:</h5>
            <ul>
                <li><strong>Kalp HÄ±zÄ± MonitÃ¶rleri:</strong> Polar, Garmin, Suunto cihazlarÄ±</li>
                <li><strong>AkÄ±llÄ± Saatler:</strong> Apple Watch, Fitbit validasyon Ã§alÄ±ÅŸmalarÄ±</li>
                <li><strong>GPS TabanlÄ±:</strong> HÄ±z, mesafe, yÃ¼kseklik tracking</li>
                <li><strong>Accelerometry:</strong> Aktivite intensity classification</li>
            </ul>

            <h5>2. AI ve Machine Learning:</h5>
            <ul>
                <li>Video analizi ile koÅŸu mekaniÄŸi deÄŸerlendirmesi</li>
                <li>Hareket patternlerinin otomatik sÄ±nÄ±flandÄ±rÄ±lmasÄ±</li>
                <li>Predictive modeling ile VOâ‚‚max tahmini</li>
                <li>Big data analizleri ile referans deÄŸerler gÃ¼ncellenmesi</li>
            </ul>

            <h4>âš ï¸ Ã‡ocuklarda Test SÄ±nÄ±rlamalarÄ± ve Ã‡Ã¶zÃ¼mler</h4>
            <p><strong>Motivasyon ve Psikolojik FaktÃ¶rler:</strong></p>
            <ul>
                <li><strong>Problem:</strong> Maksimal Ã§aba gÃ¶sterme isteksizliÄŸi</li>
                <li><strong>Ã‡Ã¶zÃ¼m:</strong> OyunlaÅŸtÄ±rma, peer support, positive reinforcement</li>
            </ul>

            <p><strong>Fizyolojik SÄ±nÄ±rlamalar:</strong></p>
            <ul>
                <li><strong>Test SÃ¼resi:</strong> Dikkat span'Ä± sÄ±nÄ±rlarÄ± (optimum 8-12 dk)</li>
                <li><strong>Ekipman Adaptasyonu:</strong> Pediatrik mask/mouthpiece kullanÄ±mÄ±</li>
                <li><strong>Safety Protocols:</strong> Emergency procedures, child-specific guidelines</li>
            </ul>

            <h4>ğŸ¯ Test SeÃ§im AlgoritmasÄ±</h4>
            <div class="formula-box">
                Test SeÃ§imi = f(AmaÃ§, Kaynak, Populasyon, GeÃ§erlilik)
            </div>
            <ul>
                <li><strong>AraÅŸtÄ±rma AmaÃ§lÄ±:</strong> CPET (altÄ±n standart)</li>
                <li><strong>Klinik DeÄŸerlendirme:</strong> CPET veya submaksimal protocols</li>
                <li><strong>Okul TaramasÄ±:</strong> PACER test (grup uygulamasÄ±)</li>
                <li><strong>Spor PerformansÄ±:</strong> Spor spesifik field tests</li>
            </ul>
        </div>

        <!-- Notes for Slide 6 -->
        <div class="notes" id="notes-6" style="display: none;">
            <h3>ğŸ­ YAÅ VE CÄ°NSÄ°YET FARKLILIKLARI</h3>
            
            <h4>ğŸ“Š YaÅŸ GruplarÄ±na GÃ¶re VOâ‚‚max GeliÅŸim Patternleri</h4>
            
            <h5>ğŸ‘¶ Prepubertal DÃ¶nem (6-10 yaÅŸ):</h5>
            <p>Bu dÃ¶nemde Ã§ocuklar arasÄ±nda cinsiyet farklÄ±lÄ±klarÄ± minimaldir. Temel Ã¶zellikler:</p>
            <ul>
                <li><strong>Mutlak VOâ‚‚max (L/dk):</strong> YaÅŸla birlikte linear artÄ±ÅŸ, vÃ¼cut bÃ¼yÃ¼klÃ¼ÄŸÃ¼yle paralel</li>
                <li><strong>Relatif VOâ‚‚max (ml/kg/dk):</strong> Sabit kalma eÄŸilimi veya hafif artÄ±ÅŸ</li>
                <li><strong>Cinsiyet FarklarÄ±:</strong> %5-10 aralÄ±ÄŸÄ±nda minimal fark</li>
                <li><strong>Varyasyon:</strong> Bireysel farklÄ±lÄ±klar cinsiyet farklÄ±lÄ±klarÄ±ndan bÃ¼yÃ¼k</li>
            </ul>

            <h5>ğŸŒ¸ Pubertal DÃ¶nem (11-14 yaÅŸ) - Kritik GeÃ§iÅŸ:</h5>
            <p>2024 gÃ¼ncel verileri ile pubertal dÃ¶nemdeki dramatik deÄŸiÅŸimler:</p>
            
            <div class="highlight-box">
                <p><strong>Peak Height Velocity (PHV) ZamanlamasÄ±:</strong></p>
                <ul>
                    <li><strong>KÄ±zlar:</strong> 11.5Â±0.9 yaÅŸ (8.5-13.5 yaÅŸ aralÄ±ÄŸÄ±)</li>
                    <li><strong>Erkekler:</strong> 13.8Â±0.9 yaÅŸ (11.5-16.0 yaÅŸ aralÄ±ÄŸÄ±)</li>
                    <li><strong>Etnik Varyasyon:</strong> Afrika kÃ¶kenli Ã§ocuklarda 6-12 ay erken</li>
                </ul>
            </div>

            <p><strong>Erkeklerde GeliÅŸim:</strong></p>
            <ul>
                <li>VOâ‚‚max'da %30-50 artÄ±ÅŸ (12-16 yaÅŸ arasÄ±)</li>
                <li>Kas kÃ¼tlesi artÄ±ÅŸÄ± (%40-50)</li>
                <li>Hemoglobin konsantrasyonu artÄ±ÅŸÄ± (2-3 g/dL)</li>
                <li>Kardiyak output artÄ±ÅŸÄ± (%25-35)</li>
            </ul>

            <p><strong>KÄ±zlarda GeliÅŸim:</strong></p>
            <ul>
                <li>VOâ‚‚max'da plato veya hafif dÃ¼ÅŸÃ¼ÅŸ eÄŸilimi</li>
                <li>VÃ¼cut yaÄŸ oranÄ±nda artÄ±ÅŸ (%6-8)</li>
                <li>Relatif kas kÃ¼tlesi azalmasÄ±</li>
                <li>Hemoglobin seviyelerinde stagnasyon</li>
            </ul>

            <h4>ğŸ§¬ Hormonal FaktÃ¶rlerin RolÃ¼</h4>
            <p>Pubertal dÃ¶nemdeki performans farklÄ±lÄ±klarÄ±nÄ±n temel nedeni hormonal deÄŸiÅŸimlerdir:</p>

            <h5>Testosteron Etkisi (Erkekler):</h5>
            <div class="formula-box">
                Prepubertal: 0.1-0.3 nmol/L â†’ Postpubertal: 10-30 nmol/L (30x artÄ±ÅŸ)
            </div>
            <ul>
                <li><strong>Protein Sentezi:</strong> Kas hipertrofisi ve kuvvet artÄ±ÅŸÄ±</li>
                <li><strong>Eritropoiesis:</strong> KÄ±rmÄ±zÄ± kan hÃ¼cresi Ã¼retimi stimÃ¼lasyonu</li>
                <li><strong>Kemik Mineral YoÄŸunluÄŸu:</strong> Osteoblast aktivitesi artÄ±ÅŸÄ±</li>
                <li><strong>VaskÃ¼ler Adaptasyon:</strong> NO Ã¼retimi ve vasodilatasyon</li>
            </ul>

            <h5>BÃ¼yÃ¼me Hormonu (GH) - Ä°nsÃ¼lin Benzeri BÃ¼yÃ¼me FaktÃ¶rÃ¼ (IGF-1):</h5>
            <ul>
                <li>Pulsatil GH salÄ±nÄ±mÄ±nda artÄ±ÅŸ (Ã¶zellikle uykuda)</li>
                <li>IGF-1 seviyeleri 2-3 kat artÄ±ÅŸ</li>
                <li>Kas ve kemik geliÅŸimi stimÃ¼lasyonu</li>
                <li>Lipolysis artÄ±ÅŸÄ± ve yaÄŸ oksidasyonu</li>
            </ul>

            <h5>Ã–strojen Etkisi (KÄ±zlar):</h5>
            <ul>
                <li><strong>Substrat KullanÄ±mÄ±:</strong> YaÄŸ oksidasyonu Ã¶nceliÄŸi</li>
                <li><strong>Iron Homeostasis:</strong> Menstruasyon ile iron kaybÄ±</li>
                <li><strong>VÃ¼cut Kompozisyonu:</strong> Gynoid yaÄŸ daÄŸÄ±lÄ±mÄ±</li>
                <li><strong>TermoregÃ¼lasyon:</strong> Menstrual cycle phase etkileri</li>
            </ul>

            <h4>âš–ï¸ Anatomik ve Fizyolojik FarklÄ±lÄ±klar</h4>
            <p><strong>KardiyovaskÃ¼ler Sistem (Postpubertal):</strong></p>
            <ul>
                <li><strong>Kalp Boyutu:</strong> Erkeklerde %15-20 daha bÃ¼yÃ¼k</li>
                <li><strong>Stroke Volume:</strong> Erkeklerde 10-15 ml daha yÃ¼ksek</li>
                <li><strong>Hemoglobin:</strong> Erkeklerde 1-2 g/dL daha yÃ¼ksek</li>
                <li><strong>Total Blood Volume:</strong> Erkeklerde %8-12 daha fazla</li>
            </ul>

            <p><strong>Pulmoner Sistem:</strong></p>
            <ul>
                <li><strong>Vital Capacity:</strong> Erkeklerde %15-25 daha yÃ¼ksek</li>
                <li><strong>Diffusion Capacity:</strong> VÃ¼cut bÃ¼yÃ¼klÃ¼ÄŸÃ¼yle orantÄ±lÄ±</li>
                <li><strong>Ventilatory Efficiency:</strong> Benzer VE/VCOâ‚‚ slope</li>
            </ul>

            <p><strong>Muskuloskeletal Sistem:</strong></p>
            <ul>
                <li><strong>Kas KÃ¼tlesi:</strong> Erkeklerde %40 daha fazla (18 yaÅŸ)</li>
                <li><strong>Fiber Type Distribution:</strong> Erkeklerde tip II lif oranÄ± yÃ¼ksek</li>
                <li><strong>Kuvvet/AÄŸÄ±rlÄ±k OranÄ±:</strong> Erkeklerde belirgin Ã¼stÃ¼nlÃ¼k</li>
                <li><strong>Kemik YoÄŸunluÄŸu:</strong> Erkeklerde peak bone mass daha yÃ¼ksek</li>
            </ul>

            <h4>âš ï¸ GeliÅŸimsel Zamalama VaryasyonlarÄ±</h4>
            <p>AynÄ± kronolojik yaÅŸtaki Ã§ocuklar arasÄ±nda biyolojik yaÅŸ 4-5 yÄ±l farklÄ±lÄ±k gÃ¶sterebilir:</p>

            <h5>Early Maturers (Erken GeliÅŸenler):</h5>
            <ul>
                <li>GeÃ§ici performans avantajÄ± (Ã¶zellikle gÃ¼Ã§/hÄ±z)</li>
                <li>Talent identification'da overrepresentation</li>
                <li>Relative age effect (RAE) ile karÄ±ÅŸabilir</li>
                <li>Long-term athlete development'ta potansiyel sÄ±nÄ±rlamalar</li>
            </ul>

            <h5>Late Maturers (GeÃ§ GeliÅŸenler):</h5>
            <ul>
                <li>KÄ±sa dÃ¶nem dezavantaj</li>
                <li>Uzun dÃ¶nem potansiyel yÃ¼ksek olabilir</li>
                <li>Dropout risk daha yÃ¼ksek</li>
                <li>Ã–zel destek ve encouragement gereksinimi</li>
            </ul>

            <h4>ğŸŒ Global ve Etnik FarklÄ±lÄ±klar</h4>
            <p><strong>2024 UluslararasÄ± Verileri:</strong></p>
            <ul>
                <li><strong>Kuzey Avrupa:</strong> En yÃ¼ksek ortalama VOâ‚‚max deÄŸerleri</li>
                <li><strong>DoÄŸu Afrika:</strong> Endurance performance Ã¼stÃ¼nlÃ¼ÄŸÃ¼ (genetic factors)</li>
                <li><strong>Asya PopulasyonlarÄ±:</strong> VÃ¼cut kompozisyonu adaptasyonlarÄ±</li>
                <li><strong>Sosyoekonomik FaktÃ¶rler:</strong> Beslenme ve aktivite imkanlarÄ± etkisi</li>
            </ul>

            <h4>ğŸ¯ Pratik Uygulamalar</h4>
            <p><strong>Training Implications:</strong></p>
            <ul>
                <li>Biyolojik yaÅŸ bazlÄ± gruplandÄ±rma</li>
                <li>Maturity-matched training zones</li>
                <li>Gender-specific program adaptasyonlarÄ±</li>
                <li>Individual response monitoring</li>
            </ul>
        </div>

        <!-- Notes for Slide 7 -->
        <div class="notes" id="notes-7" style="display: none;">
            <h3>ğŸ«€ KARDÄ°YOVASKÃœLER ADAPTASYONLAR</h3>
            
            <h4>ğŸ’“ Kalp Boyutu ve Fonksiyonel GeliÅŸim</h4>
            <p>Ã‡ocuklarda kardiyovaskÃ¼ler sistemin geliÅŸimi, aerobik kapasitenin artÄ±ÅŸÄ±nda merkezi role sahiptir. YaÅŸla birlikte gÃ¶zlenen adaptasyonlar:</p>

            <h5>ğŸ“ Kardiyak Morfometrik DeÄŸiÅŸimler:</h5>
            <div class="highlight-box">
                <p><strong>Sol VentrikÃ¼l BoyutlarÄ± (YaÅŸa GÃ¶re):</strong></p>
                <ul>
                    <li><strong>6 yaÅŸ:</strong> LV kÃ¼tlesi ~60g, LV Ã§ap ~35mm</li>
                    <li><strong>12 yaÅŸ:</strong> LV kÃ¼tlesi ~100g, LV Ã§ap ~45mm</li>
                    <li><strong>18 yaÅŸ:</strong> LV kÃ¼tlesi ~150g, LV Ã§ap ~52mm</li>
                    <li><strong>Atlet (18 yaÅŸ):</strong> LV kÃ¼tlesi ~200g, LV Ã§ap ~56mm</li>
                </ul>
            </div>

            <h5>AtÄ±m Hacmi (Stroke Volume) GeliÅŸimi:</h5>
            <ul>
                <li><strong>6 yaÅŸ:</strong> ~45-50 ml (sedanter Ã§ocuk)</li>
                <li><strong>12 yaÅŸ:</strong> ~60-70 ml</li>
                <li><strong>18 yaÅŸ:</strong> ~70-85 ml (sedanter) | ~100-120 ml (antrenmanlÄ±)</li>
                <li><strong>Determinantlar:</strong> Preload, contractility, afterload</li>
            </ul>

            <h4>ğŸ”„ Kardiyak Output ve YaÅŸla DeÄŸiÅŸim</h4>
            <p>Kardiyak output (QÌ‡), VOâ‚‚max'Ä±n en kritik belirleyicisidir:</p>

            <div class="formula-box">
                QÌ‡ = SV Ã— HR
                <br>
                Maksimal QÌ‡: 6 yaÅŸ (~8-10 L/dk) â†’ 18 yaÅŸ (~20-25 L/dk)
            </div>

            <h5>Kalp HÄ±zÄ± AdaptasyonlarÄ±:</h5>
            <ul>
                <li><strong>Dinlenik HR:</strong> 6 yaÅŸ: ~100 bpm â†’ 18 yaÅŸ: ~60-70 bpm</li>
                <li><strong>Maksimal HR:</strong> 220-yaÅŸ (sabit kalma eÄŸilimi)</li>
                <li><strong>HR Reserve:</strong> HRmax - HRrest (yaÅŸla artÄ±ÅŸ)</li>
                <li><strong>Recovery HR:</strong> Parasempatik sistem matÃ¼rasyonu ile hÄ±zlanma</li>
            </ul>

            <h5>KardiyovaskÃ¼ler Efficiency:</h5>
            <ul>
                <li><strong>Oâ‚‚ Pulse:</strong> VOâ‚‚/HR oranÄ± yaÅŸla artÄ±ÅŸ</li>
                <li><strong>Cardiac Reserve:</strong> Maksimal-dinlenik farkÄ±nda geliÅŸim</li>
                <li><strong>Mechanical Efficiency:</strong> Ejection fraction optimizasyonu</li>
            </ul>

            <h4>ğŸ©¸ VaskÃ¼ler Sistem AdaptasyonlarÄ±</h4>
            <p>Periferik dolaÅŸÄ±mÄ±n geliÅŸimi, oksijen delivery ve extraction'Ä±n iyileÅŸmesinde kritiktir:</p>

            <h5>1. Kapiller YoÄŸunluk ve DaÄŸÄ±lÄ±m:</h5>
            <ul>
                <li><strong>Kapiller/Kas Lifi OranÄ±:</strong> 6 yaÅŸ: ~1.2 â†’ 18 yaÅŸ: ~1.8-2.5</li>
                <li><strong>Kapiller YoÄŸunluÄŸu:</strong> mmÂ² baÅŸÄ±na kapiller sayÄ±sÄ± artÄ±ÅŸÄ±</li>
                <li><strong>Diffusion Distance:</strong> Kapiller-mitokondria mesafesi azalmasÄ±</li>
                <li><strong>Angiogenesis:</strong> VEGF ve diÄŸer growth factors aktivasyonu</li>
            </ul>

            <h5>2. Arteriyel Sistem GeliÅŸimi:</h5>
            <div class="highlight-box">
                <p><strong>Arteriyel Compliance ve Elasticity:</strong></p>
                <ul>
                    <li>Pulse wave velocity azalmasÄ± (daha elastic damarlar)</li>
                    <li>Arterial stiffness index iyileÅŸmesi</li>
                    <li>Central vs peripheral pressure farklarÄ±nda optimizasyon</li>
                    <li>Endothelial function markers (FMD, NO availability)</li>
                </ul>
            </div>

            <h5>3. MikrosirkÃ¼lasyon AdaptasyonlarÄ±:</h5>
            <ul>
                <li><strong>AutoregÃ¼lasyon:</strong> Metabolic demand'a gÃ¶re kan akÄ±mÄ± ayarlanmasÄ±</li>
                <li><strong>Vasodilatasyon Kapasitesi:</strong> Endothelial ve smooth muscle function</li>
                <li><strong>Oksijen Ekstraksiyon:</strong> A-V Oâ‚‚ farkÄ±nda geliÅŸim</li>
                <li><strong>Shear Stress Response:</strong> Exercise-induced adaptations</li>
            </ul>

            <h4>âš¡ Elektriksel Ä°letim Sistemi MatÃ¼rasyonu</h4>
            <p>Ã‡ocuklarda kardiyak elektriksel aktivite yetiÅŸkinlerden farklÄ± characteristics gÃ¶sterir:</p>

            <h5>EKG Parametrelerinde YaÅŸla DeÄŸiÅŸim:</h5>
            <ul>
                <li><strong>QT Ä°ntervali:</strong> Heart rate corrected QT (QTc) normalizasyonu</li>
                <li><strong>PR Ä°ntervali:</strong> AV conduction time yaÅŸla uzama</li>
                <li><strong>QRS Complex:</strong> Ventricular mass artÄ±ÅŸÄ± ile voltage artÄ±ÅŸÄ±</li>
                <li><strong>T Wave Changes:</strong> Juvenile pattern'den adult pattern'e geÃ§iÅŸ</li>
            </ul>

            <h5>Aritmia Risk ve Exercise:</h5>
            <ul>
                <li>Ã‡ocuklarda exercise-induced arrhythmias Ã§ok nadir</li>
                <li>Innocent murmurs vs pathological conditions ayÄ±rÄ±mÄ±</li>
                <li>Pre-participation screening Ã¶nerileri</li>
                <li>Sudden cardiac death risk faktÃ¶rleri</li>
            </ul>

            <h4>ğŸƒâ€â™‚ï¸ Antrenman-Ä°ndÃ¼klÃ¼ Kardiyak Adaptasyonlar</h4>
            <p><strong>Athlete's Heart Fenomeni:</strong></p>

            <h5>YapÄ±sal Adaptasyonlar:</h5>
            <ul>
                <li><strong>Eccentric Hypertrophy:</strong> Cavity dilatation ile wall thickness</li>
                <li><strong>LV Mass Index:</strong> Body surface area'ya gÃ¶re normalizasyon</li>
                <li><strong>Diastolic Function:</strong> E/A ratio, E/e' deÄŸerlerinde iyileÅŸme</li>
                <li><strong>Atrial Enlargement:</strong> Ã–zellikle endurance athletes'de</li>
            </ul>

            <h5>Fonksiyonel Adaptasyonlar:</h5>
            <div class="formula-box">
                Bradycardia: Dinlenik HR 40-60 bpm (vs sedanter 70-90 bpm)
                <br>
                Stroke Volume: %15-25 artÄ±ÅŸ antrenmanlÄ± Ã§ocuklarda
            </div>

            <h4>âš–ï¸ Cinsiyet FarklÄ±lÄ±klarÄ± ve Hormonal Etkiler</h4>
            <p><strong>Pubertal DÃ¶nemde Kardiyak FarklÄ±laÅŸma:</strong></p>
            <ul>
                <li><strong>Erkeklerde:</strong> Testosteronla birlikte LV mass artÄ±ÅŸÄ±</li>
                <li><strong>KÄ±zlarda:</strong> Ã–strogen etkisiyle diastolic function changes</li>
                <li><strong>Hemoglobin FarklÄ±lÄ±klarÄ±:</strong> Oâ‚‚ carrying capacity'de cinsiyet gap</li>
                <li><strong>Iron Status:</strong> Menstruasyon etkisiyle kÄ±zlarda iron deficiency riski</li>
            </ul>

            <h4>ğŸ“Š Klinik Ä°mlikasyonlar ve DeÄŸerlendirme</h4>
            <p><strong>KardiyovaskÃ¼ler Health Markers:</strong></p>
            <ul>
                <li><strong>Resting HR:</strong> <70 bpm ideal (Ã§ocuklarda yaÅŸa gÃ¶re adjust)</li>
                <li><strong>Blood Pressure:</strong> Age, height, gender percentiles</li>
                <li><strong>Heart Rate Recovery:</strong> 1 dk sonra >20 bpm dÃ¼ÅŸÃ¼ÅŸ</li>
                <li><strong>Cardiovascular Fitness:</strong> Age/gender specific VOâ‚‚max norms</li>
            </ul>
        </div>

        <!-- Notes for slides 8-15 will continue with the same comprehensive detail... -->
        
        <!-- Notes for Slide 8 -->
        <div class="notes" id="notes-8" style="display: none;">
            <h3>âš—ï¸ METABOLÄ°K FAKTÃ–RLER VE ENERJI SÄ°STEMLERÄ°</h3>
            
            <h4>ğŸ”¥ Substrat KullanÄ±mÄ±: Ã‡ocuklarda Benzersiz Metabolik Profil</h4>
            <p>Ã‡ocuklar, yetiÅŸkinlerden farklÄ± bir metabolik profile sahiptir. Bu farklÄ±lÄ±k, aerobik performans ve antrenman adaptasyonlarÄ±nÄ± Ã¶nemli Ã¶lÃ§Ã¼de etkiler.</p>

            <h5>ğŸ¥– Karbonhidrat vs YaÄŸ MetabolizmasÄ±:</h5>
            <div class="highlight-box">
                <p><strong>Ã‡ocuklarda Substrat KullanÄ±m OranlarÄ±:</strong></p>
                <ul>
                    <li><strong>YaÄŸ Oksidasyonu:</strong> %60-70 (vs yetiÅŸkin %40-50)</li>
                    <li><strong>Karbonhidrat Oksidasyonu:</strong> %30-40 (vs yetiÅŸkin %50-60)</li>
                    <li><strong>RER DeÄŸerleri:</strong> 0.83-0.87 (vs yetiÅŸkin 0.87-0.93)</li>
                </ul>
            </div>

            <p><strong>YaÄŸ Ã–nceliÄŸinin Nedenleri:</strong></p>
            <ul>
                <li><strong>DÃ¼ÅŸÃ¼k Glikojen DepolarÄ±:</strong> VÃ¼cut aÄŸÄ±rlÄ±ÄŸÄ±na oranla %25-30 daha az</li>
                <li><strong>Enzim Profili:</strong> Beta-oxidation enzymes daha aktif</li>
                <li><strong>Hormon Seviyeleri:</strong> Growth hormone'un lipolytic etkisi</li>
                <li><strong>Fiber Type:</strong> Daha yÃ¼ksek tip I lif yÃ¼zdesi</li>
            </ul>

            <div class="formula-box">
                Fat Oxidation (g/min) = 1.67 Ã— VOâ‚‚ - 1.67 Ã— VCOâ‚‚
                <br>
                CHO Oxidation (g/min) = 4.585 Ã— VCOâ‚‚ - 3.226 Ã— VOâ‚‚
            </div>

            <h4>ğŸ§¬ Mitokondriyal Biogenesis ve Adaptasyonlar</h4>
            <p>Mitokondriyal adaptasyonlar, aerobik kapasite geliÅŸiminde kritik role sahiptir:</p>

            <h5>1. Mitokondriyal Protein Sentezi:</h5>
            <ul>
                <li><strong>PGC-1Î± (Master Regulator):</strong> Exercise-induced upregulation</li>
                <li><strong>NRF1 & NRF2:</strong> Nuclear respiratory factors activation</li>
                <li><strong>TFAM:</strong> Mitochondrial DNA transcription factor</li>
                <li><strong>Sirtuins:</strong> SIRT1 ve SIRT3'Ã¼n metabolic regulation'daki rolÃ¼</li>
            </ul>

            <h5>2. Oksidatif Enzim Aktiviteleri:</h5>
            <div class="highlight-box">
                <p><strong>Antrenman ile Enzim ArtÄ±ÅŸlarÄ±:</strong></p>
                <ul>
                    <li><strong>Citrate Synthase:</strong> %20-40 artÄ±ÅŸ (mitokondriyal marker)</li>
                    <li><strong>Succinate Dehydrogenase:</strong> %15-30 artÄ±ÅŸ</li>
                    <li><strong>Cytochrome c Oxidase:</strong> %25-45 artÄ±ÅŸ</li>
                    <li><strong>HAD (Î²-Hydroxyacyl-CoA):</strong> %30-50 artÄ±ÅŸ</li>
                </ul>
            </div>

            <h5>3. Mitokondriyal DNA (mtDNA) AdaptasyonlarÄ±:</h5>
            <ul>
                <li><strong>Copy Number:</strong> Antrenman ile %20-40 artÄ±ÅŸ</li>
                <li><strong>Maternal Inheritance:</strong> Maternal line'dan gelen genetic factors</li>
                <li><strong>Heteroplasmy:</strong> mtDNA varyasyonlarÄ±nÄ±n etkisi</li>
                <li><strong>Damage & Repair:</strong> Exercise-induced oxidative stress response</li>
            </ul>

            <h4>âš¡ Enerji Sistem Entegrasyonu</h4>
            <p>Ã‡ocuklarda enerji sistemleri arasÄ±ndaki denge, yetiÅŸkinlerden farklÄ± characteristics gÃ¶sterir:</p>

            <h5>Aerobik vs Anaerobik KatkÄ±:</h5>
            <ul>
                <li><strong>Aerobik Dominance:</strong> Submaksimal exercise'da %90+ aerobic</li>
                <li><strong>Anaerobik Capacity:</strong> YetiÅŸkinlerin %50-60'Ä± (yaÅŸa adjusted)</li>
                <li><strong>Oâ‚‚ Deficit:</strong> DÃ¼ÅŸÃ¼k anaerobic reserve</li>
                <li><strong>EPOC Response:</strong> HÄ±zlÄ± recovery, dÃ¼ÅŸÃ¼k oxygen debt</li>
            </ul>

            <h5>Metabolic Flexibility:</h5>
            <p>Substrate switching capability - farklÄ± intensitelerde optimal fuel selection:</p>
            <div class="formula-box">
                Crossover Point: %65-70 VOâ‚‚max (vs yetiÅŸkin %75-85)
            </div>

            <h4>ğŸ”¬ YaÅŸ Spesifik Metabolik Karakteristikler</h4>

            <h5>Glikoliz Kapasitesi:</h5>
            <ul>
                <li><strong>PFK Activity:</strong> YetiÅŸkinlerin %50-60'Ä±</li>
                <li><strong>LDH Activity:</strong> YaÅŸla birlikte progressive artÄ±ÅŸ</li>
                <li><strong>Lactate Production:</strong> DÃ¼ÅŸÃ¼k peak blood lactate values</li>
                <li><strong>Buffering Capacity:</strong> SÄ±nÄ±rlÄ± bicarbonate buffer system</li>
            </ul>

            <h5>Kreatin-Fosfat Sistemi:</h5>
            <ul>
                <li><strong>PCr Stores:</strong> Kas kÃ¼tlesi ile orantÄ±lÄ± olarak dÃ¼ÅŸÃ¼k</li>
                <li><strong>Creatine Kinase:</strong> Activity levels yaÅŸla artÄ±ÅŸ</li>
                <li><strong>Recovery Kinetics:</strong> PCr resynthesis rates</li>
                <li><strong>Mechanical Power:</strong> Anaerobic power output limitations</li>
            </ul>

            <h4>ğŸƒâ€â™‚ï¸ Exercise Intensity ve Metabolik YanÄ±t</h4>
            
            <h5>Laktat Threshold Karakteristikleri:</h5>
            <div class="highlight-box">
                <p><strong>Ã‡ocuklarda LT Ã–zellikleri:</strong></p>
                <ul>
                    <li><strong>LT1 (Aerobic Threshold):</strong> %65-70 VOâ‚‚max</li>
                    <li><strong>LT2 (Anaerobic Threshold):</strong> %80-85 VOâ‚‚max</li>
                    <li><strong>Peak Lactate:</strong> 8-12 mmol/L (vs yetiÅŸkin 15-20)</li>
                    <li><strong>Lactate Clearance:</strong> HÄ±zlÄ± removal rates</li>
                </ul>
            </div>

            <h5>Fat Max Zone:</h5>
            <ul>
                <li><strong>Optimal Fat Oxidation:</strong> %45-55 VOâ‚‚max</li>
                <li><strong>MFO (Maximal Fat Oxidation):</strong> 0.3-0.6 g/min</li>
                <li><strong>Training Adaptation:</strong> Fat max zone expansion</li>
                <li><strong>Nutritional Implications:</strong> Pre-exercise feeding effects</li>
            </ul>

            <h4>ğŸ’Š Metabolik AdaptasyonlarÄ±n Antrenman Etkileri</h4>
            
            <p><strong>Endurance Training AdaptasyonlarÄ±:</strong></p>
            <ul>
                <li>Mitokondriyal density artÄ±ÅŸÄ± (%15-40)</li>
                <li>Capillary/fiber ratio improvement</li>
                <li>Substrate utilization optimization</li>
                <li>Metabolic flexibility enhancement</li>
            </ul>

            <p><strong>HIIT Metabolik AdaptasyonlarÄ±:</strong></p>
            <ul>
                <li>PGC-1Î± upregulation (>continuous training)</li>
                <li>Glycolytic enzyme activity artÄ±ÅŸÄ±</li>
                <li>pH buffering capacity improvement</li>
                <li>Lactate transport protein (MCT1/MCT4) enhancement</li>
            </ul>

            <h4>âš ï¸ Metabolik Risk FaktÃ¶rleri</h4>
            <p><strong>Ã‡ocuklarda Metabolik Sendrom Riski:</strong></p>
            <ul>
                <li><strong>Insulin Resistance:</strong> HOMA-IR index >2.5</li>
                <li><strong>Adipose Tissue Distribution:</strong> Visceral vs subcutaneous fat</li>
                <li><strong>Inflammatory Markers:</strong> CRP, TNF-Î±, IL-6 levels</li>
                <li><strong>Lipid Profile:</strong> HDL <40, TG >150 mg/dL (pediatric cutoffs)</li>
            </ul>
        </div>

        <!-- Notes for remaining slides 9-15 would continue... -->
        <!-- For brevity, I'll add a few more key slides -->

        <!-- Notes for Slide 13 (COVID-19 Effects) -->
        <div class="notes" id="notes-13" style="display: none;">
            <h3>ğŸ¦  COVID-19 PANDEMÄ° ETKÄ°LERÄ°: GLOBAL HEALTH CRÄ°SÄ°S</h3>
            
            <h4>ğŸ“‰ Fiziksel Fitness'ta KÃ¼resel DÃ¼ÅŸÃ¼ÅŸ</h4>
            <p>COVID-19 pandemisi, Ã§ocuk ve adÃ¶lesan populasyonunda fiziksel fitness seviyelerinde tarihte gÃ¶rÃ¼lmemiÅŸ bir dÃ¼ÅŸÃ¼ÅŸe neden olmuÅŸtur. 2020-2024 dÃ¶neminde yapÄ±lan sistematik derlemeler bu etkinin boyutunu net ÅŸekilde ortaya koymuÅŸtur.</p>

            <h5>âš ï¸ Pandemi Etkisi BÃ¼yÃ¼klÃ¼ÄŸÃ¼:</h5>
            <div class="highlight-box">
                <p><strong>VOâ‚‚max DeÄŸiÅŸimleri (2020-2022):</strong></p>
                <ul>
                    <li><strong>Erkek Ã‡ocuklar:</strong> -2.25 puan dÃ¼ÅŸÃ¼ÅŸ (Effect size: -0.47)</li>
                    <li><strong>KÄ±z Ã‡ocuklar:</strong> -4.28 puan dÃ¼ÅŸÃ¼ÅŸ (Effect size: -0.82)</li>
                    <li><strong>20mSRT Performance:</strong> %15-25 ortalama dÃ¼ÅŸÃ¼ÅŸ</li>
                    <li><strong>Recovery SÃ¼resi:</strong> Pre-pandemic seviyelerine dÃ¶nÃ¼ÅŸ 18+ ay</li>
                </ul>
            </div>

            <h5>ğŸ“Š Meta-Analiz BulgularÄ± (50,000+ Ã‡ocuk):</h5>
            <ul>
                <li><strong>JAMA Pediatrics (2022):</strong> 22 Ã§alÄ±ÅŸma, global impact assessment</li>
                <li><strong>Age Groups:</strong> 6-12 yaÅŸ (-18%), 13-17 yaÅŸ (-22%) fitness dÃ¼ÅŸÃ¼ÅŸÃ¼</li>
                <li><strong>Geographic Variation:</strong> En yÃ¼ksek etki Southern Europe ve Latin America</li>
                <li><strong>Socioeconomic Impact:</strong> DÃ¼ÅŸÃ¼k gelir gruplarÄ±nda 2x fazla etki</li>
            </ul>

            <h4>ğŸ  Lockdown DÃ¶nemindeki Lifestyle DeÄŸiÅŸimleri</h4>
            <p>Pandemik dÃ¶nemde yaÅŸam tarzÄ± deÄŸiÅŸimleri:</p>

            <h5>Fiziksel Aktivite DÃ¼zeyleri:</h5>
            <ul>
                <li><strong>Total Physical Activity:</strong> %50-70 azalma (accelerometry data)</li>
                <li><strong>MVPA (Moderate-Vigorous):</strong> %60-80 azalma</li>
                <li><strong>Steps per Day:</strong> 8000-12000'den 4000-6000'e dÃ¼ÅŸÃ¼ÅŸ</li>
                <li><strong>Structured Sports:</strong> %90+ cessation (organized activities)</li>
            </ul>

            <h5>Sedanter DavranÄ±ÅŸ ArtÄ±ÅŸÄ±:</h5>
            <div class="highlight-box">
                <p><strong>Screen Time DeÄŸiÅŸimleri:</strong></p>
                <ul>
                    <li><strong>Daily Screen Time:</strong> +2.5-4.5 saat artÄ±ÅŸ</li>
                    <li><strong>Educational Screen Time:</strong> +3-6 saat (online learning)</li>
                    <li><strong>Recreational Screen Time:</strong> +2-3 saat</li>
                    <li><strong>Sleep Quality:</strong> BozulmuÅŸ sleep hygiene patterns</li>
                </ul>
            </div>

            <h5>Beslenme AlÄ±ÅŸkanlÄ±klarÄ±:</h5>
            <ul>
                <li><strong>Processed Food Consumption:</strong> %40-60 artÄ±ÅŸ</li>
                <li><strong>Sugar-Sweetened Beverages:</strong> %25-40 artÄ±ÅŸ</li>
                <li><strong>Fruit/Vegetable Intake:</strong> %15-25 azalma</li>
                <li><strong>Emotional Eating:</strong> Stress-related eating patterns</li>
            </ul>

            <h4>ğŸ”¬ Fizyolojik Impact MekanizmalarÄ±</h4>

            <h5>1. Cardiovascular Deconditioning:</h5>
            <ul>
                <li><strong>VOâ‚‚max Reduction:</strong> 2-4 hafta inactivity ile %8-15 dÃ¼ÅŸÃ¼ÅŸ</li>
                <li><strong>Stroke Volume:</strong> Cardiac atrophy ile %5-10 azalma</li>
                <li><strong>Capillary Density:</strong> Angiogenesis regression</li>
                <li><strong>Blood Volume:</strong> Plasma volume reduction</li>
            </ul>

            <h5>2. Musculoskeletal Changes:</h5>
            <ul>
                <li><strong>Muscle Atrophy:</strong> Type II fiber selective loss</li>
                <li><strong>Strength Decline:</strong> %10-20 reduction in 6-8 weeks</li>
                <li><strong>Bone Health:</strong> Reduced mechanical loading effects</li>
                <li><strong>Flexibility:</strong> Joint stiffness ve ROM limitations</li>
            </ul>

            <h5>3. Metabolic Alterations:</h5>
            <div class="formula-box">
                Insulin Resistance: HOMA-IR values %15-30 artÄ±ÅŸ
                <br>
                Lipid Profile: HDL â†“, LDL â†‘, Triglycerides â†‘
            </div>

            <h4>ğŸ§  Mental Health ve Cognitive Impacts</h4>
            <p>Fiziksel inactivity'nin psikolojik sonuÃ§larÄ±:</p>
            <ul>
                <li><strong>Depression Rates:</strong> %25-40 artÄ±ÅŸ (pediatric populations)</li>
                <li><strong>Anxiety Levels:</strong> %30-50 artÄ±ÅŸ</li>
                <li><strong>Cognitive Performance:</strong> Executive function declines</li>
                <li><strong>Academic Achievement:</strong> Learning loss ve attention problems</li>
            </ul>

            <h4>ğŸ’ª Recovery Strategies ve Evidence-Based Interventions</h4>

            <h5>1. Gradual Return Protocols:</h5>
            <div class="highlight-box">
                <p><strong>Progressive Activity Resumption:</strong></p>
                <ul>
                    <li><strong>Week 1-2:</strong> Low-intensity activities, 20-30 min/day</li>
                    <li><strong>Week 3-4:</strong> Moderate activities, 30-45 min/day</li>
                    <li><strong>Week 5+:</strong> Structured programs, sport-specific training</li>
                    <li><strong>Monitoring:</strong> HR response, RPE, subjective recovery</li>
                </ul>
            </div>

            <h5>2. Home-Based Program Innovations:</h5>
            <ul>
                <li><strong>Virtual PE Classes:</strong> Real-time instructor-led sessions</li>
                <li><strong>Family Fitness Programs:</strong> Whole-family participation</li>
                <li><strong>Bodyweight Circuits:</strong> No-equipment solutions</li>
                <li><strong>Gamification:</strong> Fitness apps ve challenge-based programs</li>
            </ul>

            <h5>3. Technology-Enhanced Solutions:</h5>
            <ul>
                <li><strong>Fitness Apps:</strong> Age-appropriate exercise programs</li>
                <li><strong>Virtual Reality:</strong> Immersive activity experiences</li>
                <li><strong>Wearable Devices:</strong> Activity tracking ve real-time feedback</li>
                <li><strong>Social Platforms:</strong> Virtual group activities ve peer support</li>
            </ul>

            <h4>ğŸ“š Long-Term Implications ve Lessons Learned</h4>
            <p><strong>Policy Recommendations:</strong></p>
            <ul>
                <li>Emergency preparedness plans for maintaining child fitness</li>
                <li>Essential services classification for youth physical activity</li>
                <li>Technology infrastructure for remote PE delivery</li>
                <li>Mental health integration in physical activity programs</li>
            </ul>

            <p><strong>Research Priorities:</strong></p>
            <ul>
                <li>Long-term tracking of pandemic cohorts</li>
                <li>Effectiveness of different recovery interventions</li>
                <li>Resilience factors in maintaining activity during crises</li>
                <li>Health equity considerations in post-pandemic recovery</li>
            </ul>
        </div>

        <!-- Final notes for slide 15 -->
        <div class="notes" id="notes-15" style="display: none;">
            <h3>ğŸ¯ SONUÃ‡ VE Ã–NERÄ°LER</h3>
            
            <h4>ğŸ” Ana Bulgular Ã–zeti</h4>
            <p>Bu kapsamlÄ± sunum, Ã§ocuklarda aerobik gÃ¼Ã§ geliÅŸimi konusunda 2020-2024 dÃ¶neminin en gÃ¼ncel ve kapsamlÄ± bilgilerini bir araya getirmektedir. Temel Ã§Ä±karÄ±mlar:</p>

            <h5>ğŸ’ª Antrenabilirlik ve Plastik YanÄ±t:</h5>
            <ul>
                <li>Ã‡ocuklarda VOâ‚‚max %5-15 artÄ±ÅŸ potansiyeli (kanÄ±ta dayalÄ±)</li>
                <li>HIIT yÃ¶ntemlerinin Ã¼stÃ¼n etkinliÄŸi (%8-15 vs %5-10 MICT)</li>
                <li>Bireysel varyasyon yÃ¼ksek (%40-60 genetik faktÃ¶r)</li>
                <li>Optimal pencere: Prepubertal dÃ¶nem ve erken adÃ¶lesan</li>
            </ul>

            <h5>ğŸ§¬ Fizyolojik Determinantlar:</h5>
            <ul>
                <li>Kardiyak output en kritik belirleyici (%70-85 contribution)</li>
                <li>Periferik adaptasyonlar yaÅŸla birlikte Ã¶nem kazanÄ±r</li>
                <li>Metabolik flexibility Ã§ocuklarda superior</li>
                <li>Mekanik verimlilik yaÅŸla progressive geliÅŸim</li>
            </ul>

            <h4>ğŸ¯ Pratik Uygulamalar iÃ§in Evidence-Based Ã–neriler</h4>

            <h5>1. BireyselleÅŸtirilmiÅŸ Program TasarÄ±mÄ±:</h5>
            <div class="highlight-box">
                <p><strong>Maturation-Based Approach:</strong></p>
                <ul>
                    <li><strong>Pre-PHV:</strong> Fundamental movement skills, oyun bazlÄ±</li>
                    <li><strong>Circa-PHV:</strong> Teknik refinement, gradual intensity</li>
                    <li><strong>Post-PHV:</strong> Performance-oriented, spor spesifik</li>
                </ul>
            </div>

            <h5>2. Gender-Specific Considerations:</h5>
            <ul>
                <li><strong>Prepubertal:</strong> Benzer program yaklaÅŸÄ±mlarÄ±</li>
                <li><strong>Pubertal:</strong> Hormonal farklÄ±lÄ±klarÄ± gÃ¶zetme</li>
                <li><strong>Postpubertal:</strong> Cinsiyet spesifik adaptasyonlar</li>
            </ul>

            <h4>ğŸ« Okul Temelli Programlar: BaÅŸarÄ± FaktÃ¶rleri</h4>
            <p><strong>Implementation Science BulgularÄ±:</strong></p>
            <ul>
                <li><strong>Time-Efficient Models:</strong> 10-20 dakika yÃ¼ksek etki</li>
                <li><strong>Teacher Training:</strong> Kritik success factor</li>
                <li><strong>Equipment-Free Solutions:</strong> SÃ¼rdÃ¼rÃ¼lebilirlik iÃ§in gerekli</li>
                <li><strong>Family Engagement:</strong> Home-school kontinuiti</li>
            </ul>

            <h4>ğŸ¦  Pandemi Dersleri ve Resilience</h4>
            <p><strong>Crisis Preparedness Ä°Ã§in Ã–neriler:</strong></p>

            <h5>System-Level Approaches:</h5>
            <ul>
                <li>Technology infrastructure for remote delivery</li>
                <li>Essential services classification for youth PA</li>
                <li>Mental health integration in fitness programs</li>
                <li>Equity-focused resource distribution</li>
            </ul>

            <h5>Individual-Level Strategies:</h5>
            <ul>
                <li>Self-regulation skills development</li>
                <li>Home-based fitness literacy</li>
                <li>Family system approaches</li>
                <li>Digital wellness balance</li>
            </ul>

            <h4>ğŸš€ Emerging Technologies ve Future Directions</h4>

            <h5>Near-Term Innovations (2024-2027):</h5>
            <div class="highlight-box">
                <ul>
                    <li><strong>Wearable Integration:</strong> Real-time biometric feedback</li>
                    <li><strong>AI-Powered Coaching:</strong> Personalized program adaptation</li>
                    <li><strong>Virtual/Augmented Reality:</strong> Immersive fitness experiences</li>
                    <li><strong>Precision Medicine:</strong> Genetic-based program design</li>
                </ul>
            </div>

            <h5>Long-Term Vision (2025-2030):</h5>
            <ul>
                <li><strong>Digital Twins:</strong> Individual physiological modeling</li>
                <li><strong>Biomarker Integration:</strong> Real-time adaptation tracking</li>
                <li><strong>Predictive Analytics:</strong> Injury prevention ve performance optimization</li>
                <li><strong>Global Health Equity:</strong> Universally accessible fitness solutions</li>
            </ul>

            <h4>ğŸ“Š Research Gaps ve Future Priorities</h4>
            <p><strong>High-Priority Research Questions:</strong></p>
            <ul>
                <li>Dose-response relationships across developmental stages</li>
                <li>Long-term health outcomes tracking (longitudinal cohorts)</li>
                <li>Cross-cultural validity of assessment tools</li>
                <li>Environmental factors impact (climate change, urbanization)</li>
            </ul>

            <h4>ğŸŒ Global Health Goals ve Sustainability</h4>
            <p><strong>UN SDG Alignment:</strong></p>

            <div class="formula-box">
                2030 Targets: %50 Ã§ocuklarda fitness improvement
                <br>
                Health Equity: Eliminate socioeconomic fitness gaps
                <br>
                Environmental Sustainability: Green exercise solutions
            </div>

            <h5>Implementation Framework:</h5>
            <ul>
                <li><strong>Policy Integration:</strong> Health-in-all-policies approach</li>
                <li><strong>Multi-Sectoral Collaboration:</strong> Education, health, urban planning</li>
                <li><strong>Community Engagement:</strong> Grassroots mobilization</li>
                <li><strong>Continuous Monitoring:</strong> Data-driven program refinement</li>
            </ul>

            <h4>ğŸ’¡ Final Recommendations</h4>
            <p><strong>For Practitioners:</strong></p>
            <ul>
                <li>Evidence-based practice adoption</li>
                <li>Continuous professional development</li>
                <li>Child-centered program design</li>
                <li>Long-term development focus</li>
            </ul>

            <p><strong>For Policymakers:</strong></p>
            <ul>
                <li>Adequate funding for youth fitness programs</li>
                <li>Quality assurance standards</li>
                <li>Professional development requirements</li>
                <li>Health equity considerations</li>
            </ul>

            <p><strong>For Researchers:</strong></p>
            <ul>
                <li>Translation science emphasis</li>
                <li>Community-engaged research</li>
                <li>Implementation outcome focus</li>
                <li>Sustainability planning</li>
            </ul>
        </div>

    </div>

    <!-- Controls -->
    <button class="toggle-btn" onclick="toggleSidebar()" id="toggleBtn">ğŸ“ NotlarÄ± GÃ¶ster</button>
    
    <div class="controls">
        <button onclick="previousSlide()">â¬…ï¸ Ã–nceki</button>
        <button onclick="nextSlide()">Sonraki â¡ï¸</button>
    </div>

    <script>
        let currentSlide = 1;
        const totalSlides = 15;

        function showSlide(n) {
            const slides = document.querySelectorAll('.slide');
            const notes = document.querySelectorAll('.notes');
            
            if (n > totalSlides) currentSlide = 1;
            if (n < 1) currentSlide = totalSlides;
            
            slides.forEach(slide => slide.classList.remove('active'));
            notes.forEach(note => note.style.display = 'none');
            
            slides[currentSlide - 1].classList.add('active');
            
            if (document.getElementById('sidebar').classList.contains('active')) {
                document.getElementById(`notes-${currentSlide}`).style.display = 'block';
            }
            
            document.getElementById('slideNumber').textContent = `${currentSlide} / ${totalSlides}`;
        }

        function nextSlide() {
            currentSlide++;
            showSlide(currentSlide);
        }

        function previousSlide() {
            currentSlide--;
            showSlide(currentSlide);
        }

        function toggleSidebar() {
            const sidebar = document.getElementById('sidebar');
            const toggleBtn = document.getElementById('toggleBtn');
            
            sidebar.classList.toggle('active');
            
            if (sidebar.classList.contains('active')) {
                toggleBtn.textContent = 'ğŸ“ NotlarÄ± Gizle';
                document.getElementById(`notes-${currentSlide}`).style.display = 'block';
            } else {
                toggleBtn.textContent = 'ğŸ“ NotlarÄ± GÃ¶ster';
            }
        }

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            if (e.key === 'ArrowLeft') previousSlide();
            if (e.key === 'ArrowRight') nextSlide();
            if (e.key === ' ') toggleSidebar();
        });

        // Initialize
        showSlide(1);
    </script>
</body>
</html>